<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Different unfractionated heparin doses for preventing arterial thrombosis in children undergoing cardiac catheterization - Avila, ML - 2020 | Cochrane Library</title> <meta content="Different unfractionated heparin doses for preventing arterial thrombosis in children undergoing cardiac catheterization - Avila, ML - 2020 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010196.pub3/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Different unfractionated heparin doses for preventing arterial thrombosis in children undergoing cardiac catheterization - Avila, ML - 2020 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010196.pub3/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD010196.pub3" name="dc.identifier" scheme="DOI"/> <meta content="Different unfractionated heparin doses for preventing arterial thrombosis in children undergoing cardiac catheterization" name="citation_title"/> <meta content="Maria L Avila" name="citation_author"/> <meta content="The Hospital for Sick Children" name="citation_author_institution"/> <meta content="Prakeshkumar S Shah" name="citation_author"/> <meta content="University of Toronto Mount Sinai Hospital" name="citation_author_institution"/> <meta content="Leonardo R Brandão" name="citation_author"/> <meta content="The Hospital for Sick Children" name="citation_author_institution"/> <meta content="leonardo.brandao@sickkids.ca" name="citation_author_email"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="2" name="citation_issue"/> <meta content="10.1002/14651858.CD010196.pub3" name="citation_doi"/> <meta content="2020" name="citation_date"/> <meta content="2020/02/17" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010196.pub3/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010196.pub3/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010196.pub3/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Anticoagulants [*administration &amp; dosage]; Cardiac Catheterization [*adverse effects]; Hemorrhage [chemically induced]; Heparin [*administration &amp; dosage]; Infusions, Intravenous [methods]; Peripheral Arterial Disease [*prevention &amp; control]; Randomized Controlled Trials as Topic; Thrombosis [*prevention &amp; control]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010196.pub3&amp;doi=10.1002/14651858.CD010196.pub3&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010196.pub3&amp;doi=10.1002/14651858.CD010196.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010196.pub3&amp;doi=10.1002/14651858.CD010196.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010196.pub3&amp;doi=10.1002/14651858.CD010196.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010196.pub3&amp;doi=10.1002/14651858.CD010196.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010196.pub3&amp;doi=10.1002/14651858.CD010196.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010196.pub3&amp;doi=10.1002/14651858.CD010196.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010196.pub3&amp;doi=10.1002/14651858.CD010196.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010196.pub3&amp;doi=10.1002/14651858.CD010196.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010196.pub3&amp;doi=10.1002/14651858.CD010196.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010196.pub3&amp;doi=10.1002/14651858.CD010196.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010196.pub3&amp;doi=10.1002/14651858.CD010196.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010196.pub3&amp;doi=10.1002/14651858.CD010196.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010196.pub3&amp;doi=10.1002/14651858.CD010196.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010196.pub3&amp;doi=10.1002/14651858.CD010196.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010196.pub3&amp;doi=10.1002/14651858.CD010196.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010196.pub3&amp;doi=10.1002/14651858.CD010196.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010196.pub3&amp;doi=10.1002/14651858.CD010196.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010196.pub3&amp;doi=10.1002/14651858.CD010196.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010196.pub3&amp;doi=10.1002/14651858.CD010196.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010196.pub3&amp;doi=10.1002/14651858.CD010196.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010196.pub3&amp;doi=10.1002/14651858.CD010196.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010196.pub3&amp;doi=10.1002/14651858.CD010196.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773519000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773548000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000"}};Liferay.authToken="qy4lqFNF";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD010196\x2epub3\x26doi\x3d10\x2e1002\x2f14651858\x2eCD010196\x2epub3\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010196\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010196\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513680837000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","zh_HANT","ru","fa","fr","ko","pl","ms"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD010196.pub3",title:"Different unfractionated heparin doses for preventing arterial thrombosis in children undergoing cardiac catheterization",firstPublishedDate:"Feb 17, 2020 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Vascular Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734739000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=qy4lqFNF&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010196.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD010196.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD010196.pub3/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD010196.pub3/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010196.pub3%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD010196.pub3/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD010196.pub3/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD010196.pub3/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD010196.pub3/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD010196.PUB3" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;초록&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;쉬운 말 요약&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;pl&quot;,&quot;title&quot;:&quot;Streszczenie prostym językiem&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;Plain language summary&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD010196.pub3/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD010196.PUB3" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD010196.pub3/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD010196.pub3/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>2520 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD010196.pub3" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010196.pub3/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010196.pub3/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010196.pub3/full#CD010196-abs-0005"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010196.pub3/full#CD010196-sec-0092"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010196.pub3/full#CD010196-sec-0029"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010196.pub3/full#CD010196-sec-0030"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010196.pub3/full#CD010196-sec-0035"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010196.pub3/full#CD010196-sec-0036"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010196.pub3/full#CD010196-sec-0067"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010196.pub3/full#CD010196-sec-0086"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD010196.pub3/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010196.pub3/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010196.pub3/appendices#CD010196-sec-0097"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010196.pub3/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010196.pub3/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD010196.pub3/media/CDSR/CD010196/table_n/CD010196StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD010196.pub3/media/CDSR/CD010196/table_n/CD010196StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010196.pub3/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010196.pub3/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010196.pub3/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD010196.pub3/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD010196.pub3/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD010196.pub3/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2020 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD010196.pub3/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> <div class="inline-status-wrapper"> <ul class="cochrane-status"> <li aria-label="A new search for studies has been conducted." class="status-item up-to-date custom-tooltip" data-status="newsearch" title="A new search for studies has been conducted."> <a class="btn secondary" href="information#history">New search</a> </li> </ul> </div> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Different unfractionated heparin doses for preventing arterial thrombosis in children undergoing cardiac catheterization </h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010196.pub3/information#CD010196-cr-0002">Maria L Avila</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010196.pub3/information#CD010196-cr-0003">Prakeshkumar S Shah</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010196.pub3/information#CD010196-cr-0004"><i class="icon corresponding-author fa fa-envelope"></i>Leonardo R Brandão</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD010196.pub3/information/en#CD010196-sec-0102">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 17 February 2020 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD010196.pub3/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD010196.pub3">https://doi.org/10.1002/14651858.CD010196.pub3</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD010196-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010196-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD010196-abs-0004">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD010196-abs-0002">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD010196-abs-0003">Français</a> </li> <li class="section-language"> <a class="" href="full/ko#CD010196-abs-0011">한국어</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD010196-abs-0001" lang="en"> <section id="CD010196-sec-0001"> <h3 class="title" id="CD010196-sec-0001">Background</h3> <p>The role of cardiac catheterization in pediatrics has progressed significantly over the last two decades, evolving from a primary diagnostic tool to a primary treatment modality in children with congenital heart disease. Vascular complications, particularly arterial thrombosis, are among the most common unwanted post‐cardiac catheterization events. In 1974, unfractionated heparin proved to be superior to placebo in decreasing the incidence of arterial thrombosis in pediatric patients. However, the optimal dose of unfractionated heparin to be utilized in this setting remains a matter of controversy. This is an update of the review first published in 2014. </p> </section> <section id="CD010196-sec-0002"> <h3 class="title" id="CD010196-sec-0002">Objectives</h3> <p>To evaluate the use of low‐dose (&lt; 100 units/kg) versus high‐dose (≥ 100 units/kg) unfractionated heparin administered as an intravenous bolus at the time of initiation of cardiac catheterization (that is, immediately after arterial puncture), with or without subsequent heparin maintenance doses, for the prevention of post‐procedural arterial thrombosis in children. </p> </section> <section id="CD010196-sec-0003"> <h3 class="title" id="CD010196-sec-0003">Search methods</h3> <p>The Cochrane Vascular Information Specialist searched the Cochrane Vascular Specialised Register, CENTRAL, MEDLINE, Embase and CINAHL databases and World Health Organization International Clinical Trials Registry Platform and ClinicalTrials.gov trials registers to 15 October 2019. We planned to undertake reference checking of identified trials to identify additional studies. No language restrictions were applied. </p> </section> <section id="CD010196-sec-0004"> <h3 class="title" id="CD010196-sec-0004">Selection criteria</h3> <p>We included randomized or quasi‐randomized trials that compared low dose to high dose unfractionated heparin administered prior to cardiac catheterization. We selected studies conducted in children aged 0 to 18 years. </p> </section> <section id="CD010196-sec-0005"> <h3 class="title" id="CD010196-sec-0005">Data collection and analysis</h3> <p>The first screening of potentially eligible studies was conducted by one of the authors (MLA). The second screening, risk of bias assessment and data extraction were independently conducted by two authors (MLA, LRB). Outcomes (thrombotic events, bleeding complications, other complications) were treated as dichotomous variables. The effect measures used were risk ratio (RR), risk difference (RD) and number needed to treat (NNT), with 95% confidence intervals (CI). We assessed the certainty of evidence for each outcome using the GRADE approach. </p> </section> <section id="CD010196-sec-0006"> <h3 class="title" id="CD010196-sec-0006">Main results</h3> <p>We identified no new studies for inclusion in this review. In total, two studies with a total of 492 participants were included. We had concerns about risk of bias for one of the two studies. The certainty of the evidence for our key outcomes was downgraded to moderate due to risk of bias concerns and imprecision. The confidence interval for the risk of arterial thrombotic events was compatible with benefits of either high or low unfractionated heparin dose regimens (RR low‐dose versus high‐dose 1.06, 95% CI 0.58 to 1.92). Only one of the studies reported the frequency of bleeding events and found no clear difference in the incidence of major or minor bleeding events between arms (RR low‐dose versus high‐dose 2.96, 95% CI 0.12 to 71.34 for major bleeding events; RR low‐dose versus high‐dose 1.38, 95% CI 0.46 to 4.13 for minor bleeding). This study also reported on the incidence of deep vein thrombosis when comparing the high versus low dose of heparin and reported a non‐significant difference (RR low‐dose versus high‐dose 0.34, 95% CI 0.01 to 8.28). The other study lacked information about bleeding. Additional side effects of heparin other than bleeding events were not reported in either of the studies. </p> </section> <section id="CD010196-sec-0007"> <h3 class="title" id="CD010196-sec-0007">Authors' conclusions</h3> <p>Due to the limitations of the current evidence, small number of included studies, and lack of details reported in one study, we are unable to determine the effects of different dosing regimens of unfractionated heparin for the prevention of vascular thrombosis during cardiac catheterization in children. Further adequately powered, randomized clinical trials are needed. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD010196-abs-0005" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010196-abs-0005">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD010196-abs-0010">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD010196-abs-0008">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD010196-abs-0009">Français</a> </li> <li class="section-language"> <a class="" href="full/ko#CD010196-abs-0012">한국어</a> </li> <li class="section-language"> <a class="" href="full/ms#CD010196-abs-0014">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/pl#CD010196-abs-0013">Polski</a> </li> <li class="section-language"> <a class="" href="full/ru#CD010196-abs-0007">Русский</a> </li> <li class="section-language"> <a class="" href="full/zh_HANT#CD010196-abs-0006">繁體中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD010196-abs-0005" lang="en"> <h3>Heparin regimens to prevent arterial thrombosis in children requiring heart catheterization</h3> <p><b>Background</b> </p> <p>Children with heart defects since birth (that is, congenital heart disease) frequently undergo a particular type of invasive procedure termed cardiac catheterization, to help diagnose or correct their condition. This procedure consists of inserting a flexible plastic tube (catheter) into the blood vessels of the patient and guiding it to his or her heart, where a dye is injected before pictures of the heart are taken. Children undergoing this type of procedure may suffer unwanted complications in the arteries into which the catheter is inserted. It is estimated that approximately 1 out of 5 to 10 patients develop arterial blood clots (that is, thrombosis) and thus require additional treatment to prevent those clots from growing further. </p> <p>Heparin, a medication known as a 'blood thinner' (that is, an anticoagulant drug), employed in clinical practice since 1935, has been used to decrease the number of arterial blood clots during heart catheterization. However, the best dose of heparin to be used in children during heart catheterization remains to be determined. </p> <p><b>Key results</b> </p> <p>This review included two small randomized controlled trials with a total of 492 participants (current until 15 October 2019). These two studies found imprecise evidence that the risk of arterial clots was similar in both the low‐dose and high‐dose heparin groups. Only one study reported bleeding and the frequency of clots in veins, which were also not different between groups. Side effects of heparin other than bleeding were not reported in either of the studies. </p> <p><b>Certainty of the evidence</b> </p> <p>The certainty of the evidence provided by these studies is moderate. We downgraded the certainty of evidence from high to moderate due to the small size and number of studies and concerns over the methods used (risk of bias). Further larger studies are needed to determine the effects of different heparin doses. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD010196-sec-0092" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD010196-sec-0092"></div> <h3 class="title" id="CD010196-sec-0093">Implications for practice</h3> <section id="CD010196-sec-0093"> <p>Due to the limitations of the current evidence, small number of included studies, and lack of details reported in one study, we are unable to determine the effects of different dosing regimens of unfractionated heparin for the prevention of vascular thrombosis during cardiac catheterization in children. </p> <p>Information about the incidence of bleeding events was incomplete in one of the trials. Interpretation of the results of these trials should combine data on both the efficacy (that is, incidence of arterial thrombosis) and safety (that is, incidence of bleeding events) of the interventions in such way that potential benefits of each intervention could be considered in the context of its side effects. There is a lack of safety information in one of the trials. </p> </section> <h3 class="title" id="CD010196-sec-0094">Implications for research</h3> <section id="CD010196-sec-0094"> <p>Despite the fact that one of the studies was designed as a superiority trial, a non‐inferiority design is also a suitable option. That is, lower doses of heparin may not be significantly superior in terms of the efficacy outcome but are perhaps safer. We therefore estimated the sample size for a non‐inferiority trial comparing high versus low doses of heparin, as follows. Given that the reported incidence of arterial thrombosis is approximately 6% to 8%, a trial evaluating non‐inferiority of 50 units/kg (intervention) in comparison to 100 to 150 units/kg of heparin (control) would require at least 775 patients per group to achieve 80% power to detect a non‐inferiority margin difference between the group proportions of 3%. The non‐inferiority margin was established at 3% because this figure is to close the frequency range of thrombotic events reported in the pediatric literature, and is thus deemed an acceptable risk. The reference group proportion was assumed to be 9% under the null hypothesis of inferiority. The power was computed for the case when the actual treatment group proportion was 6%. The significance level of the test was targeted at 0.05. Therefore, a larger randomized trial will be required to answer the question of this review. The similarity between the results of studies included in the review and those of the non‐randomized prospective studies included in the <a href="#CD010196-sec-0091">Agreements and disagreements with other studies or reviews</a> section strengthens the case for conducting a proper randomized controlled trial. Future studies should take into account the age‐dependency of hemostasis and drug metabolism and researchers should ensure adequate representation of younger patients in the study. Lastly, whereas the measurement of thrombotic and bleeding complications is an essential component of any future study, determination and correlation with laboratory monitoring parameters is equally relevant. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD010196-sec-0029" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD010196-sec-0029"></div> <div class="table" id="CD010196-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Different unfractionated heparin doses for preventing arterial thrombosis in children undergoing cardiac catheterization</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Low unfractionated heparin (UFH) dose compared with high UFH dose for prevention of arterial thrombosis during cardiac catheterization (CC)</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> children with congenital heart disease undergoing CC </p> <p><b>Settings:</b> hospital </p> <p><b>Intervention:</b> low doses of UFH (&lt; 100 units/kg) </p> <p><b>Comparison:</b> high doses of UFH (≥ 100 units/kg) </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects * (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>No of Participants<br/> (RCTs)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with high dose UFH</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with low dose UFH</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Arterial thrombotic events</b> </p> <p>(6 to 48 hours after CC)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>7.7 per 100 procedures</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>8.2 per 100 procedures</b><br/> (5.3 to 12.3)<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.06</b> (0.58 to 1.92) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>492<br/> (2) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate<sup>b</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Different detection methods used. <a href="./references#CD010196-bbs2-0002" title="SaxenaA , GuptaR , KumarRK , KothariSS , WasirHS . Predictors of arterial thrombosis after diagnostic cardiac catheterization in infants and children randomized to two heparin dosages. Catheterization and Cardiovascular Diagnosis1997;41(4):400‐3. ">Saxena 1997</a> used clinical assessment and <a href="./references#CD010196-bbs2-0001" title="EUCTR2005‐004150‐27‐AT . Randomized controlled trial comparing two heparinization protocols for prophylaxis of short‐ and long‐term thrombotic complications of pediatric cardiac catheterization the HEARTCAT‐Study (HEparin Anticoagulation Randomised Trial for Cardiac Catheterization). apps.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2005‐004150‐27‐AT (first posted 12 December 2005). HanslikA , KitzmullerE , HaumerM , KarapetianH , ThomK , Salzer‐MuharU , et al. Incidence of thrombotic and bleeding complications during cardiac catheterization in children (HEARTCAT‐study). Journal of Thrombosis and Haemostasis2009;7(Suppl 2):465. HanslikA , KitzmullerE , Mlekusch , W , Salzer‐MuharU , Michel‐BehnkeI , MaleC . Randomized controlled trial comparing two heparinization protocols for prophylaxis of vascular thrombosis during cardiac catheterization in children ‐ the HEARTCAT study. Cardiology in the Young. Conference: 44th Annual Meeting of the Association for European Paediatric Cardiology, AEPC with Joint Sessions with the Japanese Society of Pediatric Cardiology and Cardiac Surgery Innsbruck Austria. 2010; Vol. 20:S39. HanslikA , KitzmullerE , ThomK , HaumerM , MlekuschW , Salzer‐MuharU , et al. Incidence of thrombotic and bleeding complications during cardiac catheterization in children: comparison of high‐dose versus low‐dose heparin protocols. Journal of Thrombosis and Haemostasis2011;9(12):2353‐60. Hanslik , A , Kitzmüller , E , Thom , K , Haumer , M , Salzer‐Muhar , U , Michel‐Behnke , I , Male , C . Comparison of high‐dose versus low‐dose heparinization protocols for prophylaxis of thrombotic complications during cardiac catheterization in children (HEARTCAT study). Hamostaseologie2010;30(1):A14. KitzmullerE , HanslikA , KarapetianH , Salzer‐MuharU , Michel‐BehnkeI , MaleC . Monitoring unfractionated heparin during cardiac catheterization in children – results from the HEARTCAT study. Cardiology in the Young. Conference: 44th Annual Meeting of the Association for European Paediatric Cardiology, AEPC with Joint Sessions with the Japanese Society of Pediatric Cardiology and Cardiac Surgery Innsbruck Austria. 2010; Vol. 20:s95. ">Hanslik 2011</a> used ultrasound assessment </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Major bleeding events</b> </p> <p>(timing not specified)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>0 per 100 procedures</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>1.5 per 100 procedures</b> (&lt; 0.01 to 8)<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 2.96</b> (0.12 to 71.34) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>137</p> <p>(1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate<sup>c</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Only <a href="./references#CD010196-bbs2-0001" title="EUCTR2005‐004150‐27‐AT . Randomized controlled trial comparing two heparinization protocols for prophylaxis of short‐ and long‐term thrombotic complications of pediatric cardiac catheterization the HEARTCAT‐Study (HEparin Anticoagulation Randomised Trial for Cardiac Catheterization). apps.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2005‐004150‐27‐AT (first posted 12 December 2005). HanslikA , KitzmullerE , HaumerM , KarapetianH , ThomK , Salzer‐MuharU , et al. Incidence of thrombotic and bleeding complications during cardiac catheterization in children (HEARTCAT‐study). Journal of Thrombosis and Haemostasis2009;7(Suppl 2):465. HanslikA , KitzmullerE , Mlekusch , W , Salzer‐MuharU , Michel‐BehnkeI , MaleC . Randomized controlled trial comparing two heparinization protocols for prophylaxis of vascular thrombosis during cardiac catheterization in children ‐ the HEARTCAT study. Cardiology in the Young. Conference: 44th Annual Meeting of the Association for European Paediatric Cardiology, AEPC with Joint Sessions with the Japanese Society of Pediatric Cardiology and Cardiac Surgery Innsbruck Austria. 2010; Vol. 20:S39. HanslikA , KitzmullerE , ThomK , HaumerM , MlekuschW , Salzer‐MuharU , et al. Incidence of thrombotic and bleeding complications during cardiac catheterization in children: comparison of high‐dose versus low‐dose heparin protocols. Journal of Thrombosis and Haemostasis2011;9(12):2353‐60. Hanslik , A , Kitzmüller , E , Thom , K , Haumer , M , Salzer‐Muhar , U , Michel‐Behnke , I , Male , C . Comparison of high‐dose versus low‐dose heparinization protocols for prophylaxis of thrombotic complications during cardiac catheterization in children (HEARTCAT study). Hamostaseologie2010;30(1):A14. KitzmullerE , HanslikA , KarapetianH , Salzer‐MuharU , Michel‐BehnkeI , MaleC . Monitoring unfractionated heparin during cardiac catheterization in children – results from the HEARTCAT study. Cardiology in the Young. Conference: 44th Annual Meeting of the Association for European Paediatric Cardiology, AEPC with Joint Sessions with the Japanese Society of Pediatric Cardiology and Cardiac Surgery Innsbruck Austria. 2010; Vol. 20:s95. ">Hanslik 2011</a> reported major bleeding </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Minor bleeding events</b> </p> <p>(timing not specified)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>7.4 per 100 procedures</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>10.1 per 100 procedures</b> (4 to 20)<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.38</b> (0.46 to 4.13) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>137</p> <p>(1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate<sup>c</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Only <a href="./references#CD010196-bbs2-0001" title="EUCTR2005‐004150‐27‐AT . Randomized controlled trial comparing two heparinization protocols for prophylaxis of short‐ and long‐term thrombotic complications of pediatric cardiac catheterization the HEARTCAT‐Study (HEparin Anticoagulation Randomised Trial for Cardiac Catheterization). apps.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2005‐004150‐27‐AT (first posted 12 December 2005). HanslikA , KitzmullerE , HaumerM , KarapetianH , ThomK , Salzer‐MuharU , et al. Incidence of thrombotic and bleeding complications during cardiac catheterization in children (HEARTCAT‐study). Journal of Thrombosis and Haemostasis2009;7(Suppl 2):465. HanslikA , KitzmullerE , Mlekusch , W , Salzer‐MuharU , Michel‐BehnkeI , MaleC . Randomized controlled trial comparing two heparinization protocols for prophylaxis of vascular thrombosis during cardiac catheterization in children ‐ the HEARTCAT study. Cardiology in the Young. Conference: 44th Annual Meeting of the Association for European Paediatric Cardiology, AEPC with Joint Sessions with the Japanese Society of Pediatric Cardiology and Cardiac Surgery Innsbruck Austria. 2010; Vol. 20:S39. HanslikA , KitzmullerE , ThomK , HaumerM , MlekuschW , Salzer‐MuharU , et al. Incidence of thrombotic and bleeding complications during cardiac catheterization in children: comparison of high‐dose versus low‐dose heparin protocols. Journal of Thrombosis and Haemostasis2011;9(12):2353‐60. Hanslik , A , Kitzmüller , E , Thom , K , Haumer , M , Salzer‐Muhar , U , Michel‐Behnke , I , Male , C . Comparison of high‐dose versus low‐dose heparinization protocols for prophylaxis of thrombotic complications during cardiac catheterization in children (HEARTCAT study). Hamostaseologie2010;30(1):A14. KitzmullerE , HanslikA , KarapetianH , Salzer‐MuharU , Michel‐BehnkeI , MaleC . Monitoring unfractionated heparin during cardiac catheterization in children – results from the HEARTCAT study. Cardiology in the Young. Conference: 44th Annual Meeting of the Association for European Paediatric Cardiology, AEPC with Joint Sessions with the Japanese Society of Pediatric Cardiology and Cardiac Surgery Innsbruck Austria. 2010; Vol. 20:s95. ">Hanslik 2011</a> reported minor bleeding </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Other thrombotic events: venous thrombosis</b> </p> <p>(up to 48 hours after CC)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>1.5 per 100 procedures</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>0 per 100 procedures</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.34</b> (0.01 to 8.28) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>126</p> <p>(1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate<sup>c</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Only <a href="./references#CD010196-bbs2-0001" title="EUCTR2005‐004150‐27‐AT . Randomized controlled trial comparing two heparinization protocols for prophylaxis of short‐ and long‐term thrombotic complications of pediatric cardiac catheterization the HEARTCAT‐Study (HEparin Anticoagulation Randomised Trial for Cardiac Catheterization). apps.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2005‐004150‐27‐AT (first posted 12 December 2005). HanslikA , KitzmullerE , HaumerM , KarapetianH , ThomK , Salzer‐MuharU , et al. Incidence of thrombotic and bleeding complications during cardiac catheterization in children (HEARTCAT‐study). Journal of Thrombosis and Haemostasis2009;7(Suppl 2):465. HanslikA , KitzmullerE , Mlekusch , W , Salzer‐MuharU , Michel‐BehnkeI , MaleC . Randomized controlled trial comparing two heparinization protocols for prophylaxis of vascular thrombosis during cardiac catheterization in children ‐ the HEARTCAT study. Cardiology in the Young. Conference: 44th Annual Meeting of the Association for European Paediatric Cardiology, AEPC with Joint Sessions with the Japanese Society of Pediatric Cardiology and Cardiac Surgery Innsbruck Austria. 2010; Vol. 20:S39. HanslikA , KitzmullerE , ThomK , HaumerM , MlekuschW , Salzer‐MuharU , et al. Incidence of thrombotic and bleeding complications during cardiac catheterization in children: comparison of high‐dose versus low‐dose heparin protocols. Journal of Thrombosis and Haemostasis2011;9(12):2353‐60. Hanslik , A , Kitzmüller , E , Thom , K , Haumer , M , Salzer‐Muhar , U , Michel‐Behnke , I , Male , C . Comparison of high‐dose versus low‐dose heparinization protocols for prophylaxis of thrombotic complications during cardiac catheterization in children (HEARTCAT study). Hamostaseologie2010;30(1):A14. KitzmullerE , HanslikA , KarapetianH , Salzer‐MuharU , Michel‐BehnkeI , MaleC . Monitoring unfractionated heparin during cardiac catheterization in children – results from the HEARTCAT study. Cardiology in the Young. Conference: 44th Annual Meeting of the Association for European Paediatric Cardiology, AEPC with Joint Sessions with the Japanese Society of Pediatric Cardiology and Cardiac Surgery Innsbruck Austria. 2010; Vol. 20:s95. ">Hanslik 2011</a> reported venous thrombosis </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Additional side effects of heparin</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Neither <a href="./references#CD010196-bbs2-0001" title="EUCTR2005‐004150‐27‐AT . Randomized controlled trial comparing two heparinization protocols for prophylaxis of short‐ and long‐term thrombotic complications of pediatric cardiac catheterization the HEARTCAT‐Study (HEparin Anticoagulation Randomised Trial for Cardiac Catheterization). apps.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2005‐004150‐27‐AT (first posted 12 December 2005). HanslikA , KitzmullerE , HaumerM , KarapetianH , ThomK , Salzer‐MuharU , et al. Incidence of thrombotic and bleeding complications during cardiac catheterization in children (HEARTCAT‐study). Journal of Thrombosis and Haemostasis2009;7(Suppl 2):465. HanslikA , KitzmullerE , Mlekusch , W , Salzer‐MuharU , Michel‐BehnkeI , MaleC . Randomized controlled trial comparing two heparinization protocols for prophylaxis of vascular thrombosis during cardiac catheterization in children ‐ the HEARTCAT study. Cardiology in the Young. Conference: 44th Annual Meeting of the Association for European Paediatric Cardiology, AEPC with Joint Sessions with the Japanese Society of Pediatric Cardiology and Cardiac Surgery Innsbruck Austria. 2010; Vol. 20:S39. HanslikA , KitzmullerE , ThomK , HaumerM , MlekuschW , Salzer‐MuharU , et al. Incidence of thrombotic and bleeding complications during cardiac catheterization in children: comparison of high‐dose versus low‐dose heparin protocols. Journal of Thrombosis and Haemostasis2011;9(12):2353‐60. Hanslik , A , Kitzmüller , E , Thom , K , Haumer , M , Salzer‐Muhar , U , Michel‐Behnke , I , Male , C . Comparison of high‐dose versus low‐dose heparinization protocols for prophylaxis of thrombotic complications during cardiac catheterization in children (HEARTCAT study). Hamostaseologie2010;30(1):A14. KitzmullerE , HanslikA , KarapetianH , Salzer‐MuharU , Michel‐BehnkeI , MaleC . Monitoring unfractionated heparin during cardiac catheterization in children – results from the HEARTCAT study. Cardiology in the Young. Conference: 44th Annual Meeting of the Association for European Paediatric Cardiology, AEPC with Joint Sessions with the Japanese Society of Pediatric Cardiology and Cardiac Surgery Innsbruck Austria. 2010; Vol. 20:s95. ">Hanslik 2011</a> or <a href="./references#CD010196-bbs2-0002" title="SaxenaA , GuptaR , KumarRK , KothariSS , WasirHS . Predictors of arterial thrombosis after diagnostic cardiac catheterization in infants and children randomized to two heparin dosages. Catheterization and Cardiovascular Diagnosis1997;41(4):400‐3. ">Saxena 1997</a> reported on additional side effects of heparin use </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CC:</b> Cardiac catheterization;<b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; <b>UFH:</b> Unfractionated heparin; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup> 95% CI by modified Wald method (<a href="./references#CD010196-bbs2-0047" title="MotulskyH . Intuitive biostatistics: a nonmathematical guide to statistical thinking. Oxford University Press, 2010. ">Motulsky 2010</a>)<br/> <sup>b</sup> We downgraded the certainty of the evidence due to imprecision and risk of bias concerns (potential limitations in design and implementation of <a href="./references#CD010196-bbs2-0002" title="SaxenaA , GuptaR , KumarRK , KothariSS , WasirHS . Predictors of arterial thrombosis after diagnostic cardiac catheterization in infants and children randomized to two heparin dosages. Catheterization and Cardiovascular Diagnosis1997;41(4):400‐3. ">Saxena 1997</a>)<br/> <sup>c</sup> We downgraded the certainty of the evidence due to imprecision </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD010196-sec-0030" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD010196-sec-0030"></div> <section id="CD010196-sec-0031"> <h3 class="title" id="CD010196-sec-0031">Description of the condition</h3> <p>Cardiac catheterization (CC) was introduced in pediatrics in the 1950s (<a href="./references#CD010196-bbs2-0015" title="Boijsen , E , Lundstrom , N . Percutaneous cardiac catheterization and angiocardiography in infants and children. American Journal of Cardiology1968;22(4):572‐5. ">Boijsen 1968</a>; <a href="./references#CD010196-bbs2-0059" title="VladP , HohnA , LambertEC . Retrograde arterial catheterization of the left heart: experience with 500 infants and children. Circulation1964;29:787‐93. ">Vlad 1964</a>). Vascular complications, particularly thrombosis of the catheterized vessel, were immediately recognized as the most common and serious complications of this technique among children (<a href="./references#CD010196-bbs2-0005" title="FreedMD , KeaneJ , RosenthalA . The use of heparinization to prevent arterial thrombosis after percutaneous cardiac catheterization in children. Circulation1974;50:565‐9. ">Freed 1974</a>; <a href="./references#CD010196-bbs2-0033" title="HohnAR , CraenenJ , LambertEC . Arterial pulses following percutaneous catheterization in children. Pediatrics1969;43(4):617‐20. ">Hohn 1969</a>; <a href="./references#CD010196-bbs2-0034" title="HurwitzRA , FrankenEAJr , GirodDA , SmithJA , SmithWL . Angiographic determination of arterial patency after percutaneous catheterization in infants and small children. Circulation1977;56(1):102‐5. ">Hurwitz 1977</a>; <a href="./references#CD010196-bbs2-0055" title="StangerP , HeymannMA , TarnoffH , HoffmanJI , RudolphAM . Complications of cardiac catheterization of neonates, infants, and children: a three‐year study. Circulation1974;50(3):595‐608. ">Stanger 1974</a>). Despite the use of systemic anticoagulation and the improved techniques, equipment, and expertise of operators, arterial vascular occlusion remains the most frequent complication of CC in pediatric patients (<a href="./references#CD010196-bbs2-0017" title="CassidySC , SchmidtKG , VanHareGF , StangerP , TeitelDF . Complications of pediatric cardiac catheterization: a 3‐year study. Journal of the American College of Cardiology1992;19(6):1285‐93. ">Cassidy 1992</a>; <a href="./references#CD010196-bbs2-0021" title="FellowsKE , RadtkeW , KeaneJF , LockJE . Acute complications of catheter therapy for congenital heart disease. American Journal of Cardiology1987;60(8):679‐83. ">Fellows 1987</a>; <a href="./references#CD010196-bbs2-0038" title="KulkarniS , NaiduR . Vascular ultrasound imaging to study immediate post catheterization vascular complications in children. Catheterization and Cardiovascular Interventions2006;68(3):450‐5. ">Kulkarni 2006</a>; <a href="./references#CD010196-bbs2-0043" title="MehtaR , LeeKJ , ChaturvediR , BensonL . Complications of pediatric cardiac catheterization: a review in the current era. Catheterization and Cardiovascular Interventions2008;72(2):278‐85. ">Mehta 2008</a>), particularly in small infants. </p> <p>Overall, arterial thrombosis has been reported in 8.5 per 10,000 pediatric hospital admissions (<a href="./references#CD010196-bbs2-0045" title="MonagleP , NewallF , BarnesC , SavoiaH , CampbellJ , WallaceT , et al. Arterial thromboembolic disease: a single‐centre case series study. Journal of Paediatrics and Child Health2008;44(1‐2):28‐32. ">Monagle 2008</a>). Catheter‐related peripheral arterial thrombosis comprises the vast majority of the pediatric cases, mostly of an iatrogenic nature secondary to arterial catheterization (<a href="./references#CD010196-bbs2-0010" title="AlbisettiM , SchmuggeM , HaasR , EckhardtBP , BauersfeldU , BaenzigerO , et al. Arterial thromboembolic complications in critically ill children. Journal of Critical Care2005;20(3):296‐300. ">Albisetti 2005</a>; <a href="./references#CD010196-bbs2-0014" title="BalciYI , UnalS , GumrukF , CetinM , OzkutluS , GurgeyA . Nonstroke arterial thrombosis in children: Hacettepe experience. Blood Coagulation and Fibrinolysis2008;19(6):519‐24. ">Balci 2008</a>). Well‐designed prospective studies have shown the incidence of Doppler detected thrombotic complications following catheterization to be 32% in infants and 7.8% in children (<a href="./references#CD010196-bbs2-0037" title="KocisKC , SniderAR , VermilionRP , BeekmanRH . Two‐dimensional and Doppler ultrasound evaluation of femoral arteries in infants after cardiac catheterization. American Journal of Cardiology1995;75(8):642‐5. ">Kocis 1995</a>; <a href="./references#CD010196-bbs2-0038" title="KulkarniS , NaiduR . Vascular ultrasound imaging to study immediate post catheterization vascular complications in children. Catheterization and Cardiovascular Interventions2006;68(3):450‐5. ">Kulkarni 2006</a>). </p> <p>Thrombotic complications at the puncture site and potential extension into the ileo‐femoral arterial system are serious events (<a href="./references#CD010196-bbs2-0046" title="MonagleP , ChanAV , GoldenbergNA , IchordRN , JourneucakeJM , Nowak‐GöttleU , et al. American College of Chest Physicians. Antithrombotic therapy in neonates and children: Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence‐Based Clinical Practice Guidelines. Chest2012;141(2 Suppl):e737S‐801S. ">Monagle 2012</a>), particularly in cases with an immediate risk of limb loss or bleeding from the use of thrombolytic or anticoagulant therapy (<a href="./references#CD010196-bbs2-0010" title="AlbisettiM , SchmuggeM , HaasR , EckhardtBP , BauersfeldU , BaenzigerO , et al. Arterial thromboembolic complications in critically ill children. Journal of Critical Care2005;20(3):296‐300. ">Albisetti 2005</a>; <a href="./references#CD010196-bbs2-0046" title="MonagleP , ChanAV , GoldenbergNA , IchordRN , JourneucakeJM , Nowak‐GöttleU , et al. American College of Chest Physicians. Antithrombotic therapy in neonates and children: Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence‐Based Clinical Practice Guidelines. Chest2012;141(2 Suppl):e737S‐801S. ">Monagle 2012</a>). Long‐term consequences of vessel obstruction include impaired limb growth, reported in 8% of children evaluated five to 14 years after catheterization (<a href="./references#CD010196-bbs2-0042" title="MacnicolMF , AnagnostopoulosJ . Arrest of the growth plate after arterial cannulation in infancy. Journal of Bone and Joint Surgery2000;82(2):172‐5. ">Macnicol 2000</a>; <a href="./references#CD010196-bbs2-0050" title="PeusterM , FreihorstJ , HausdorfG . Images in cardiology. Defective limb growth after retrograde balloon valvuloplasty. Heart2000;84(1):63. ">Peuster 2000</a>; <a href="./references#CD010196-bbs2-0056" title="TaylorLMJr , TroutmanR , FelicianoP , MenasheV , SunderlandC , PorterJM . Late complications after femoral artery catheterization in children less than five years of age. Journal of Vascular Surgery1990;11(2):297‐304; discussion 304‐6. ">Taylor 1990</a>), muscle wasting, claudication, and loss of arterial access for future catheterizations in up to 30% of previously catheterized children and adolescents (<a href="./references#CD010196-bbs2-0018" title="CelermajerDS , RobinsonJT , TaylorJF . Vascular access in previously catheterised children and adolescents: a prospective study of 131 consecutive cases. British Heart Journal1993;70(6):554‐7. ">Celermajer 1993</a>), which is highly relevant to children who require repeated CC (<a href="./references#CD010196-bbs2-0012" title="AndrewM , DavidM , deVeberG , BrookerLA . Arterial thromboembolic complications in paediatric patients. Thrombosis and Haemostasis1997;78(1):715‐25. ">Andrew 1997</a>; <a href="./references#CD010196-bbs2-0013" title="BalaguruD , DilawarM , RuffP , RadtkeWA . Early and late results of thrombolytic therapy using tissue‐type plasminogen activator to restore arterial pulse after cardiac catheterization in infants and small children. American Journal of Cardiology2003;91(7):908‐10. ">Balaguru 2003</a>). </p> </section> <section id="CD010196-sec-0032"> <h3 class="title" id="CD010196-sec-0032">Description of the intervention</h3> <p>In the early 1970s, observational studies conducted in adult patients showed that peri‐procedural unfractionated heparin (UFH) injection was associated with a lower frequency of thrombotic events at the site of insertion of angiographic catheters (<a href="./references#CD010196-bbs2-0020" title="EyerKM . Complications of transfemoral coronary arteriography and their prevention using heparin. American Heart Journal1973;86(3):428. ">Eyer 1973</a>; <a href="./references#CD010196-bbs2-0060" title="WalkerWJ , MundallSL , BroderickHG , PrasadB , KimJ , RaviJM . Systemic heparinization for femoral percutaneous coronary arteriography. New England Journal of Medicine1973;288(16):826‐8. ">Walker 1973</a>; <a href="./references#CD010196-bbs2-0061" title="WallaceS , MedellinH , deJonghD , GianturcoC . Systemic heparinization for angiography. The American Journal of Roentgenology Radium Therapy and Nuclear Medicine1972;116(1):204‐9. ">Wallace 1972</a>). These initial findings legitimized the current practice of systemic anticoagulation during CC, initially much feared and warned against due to the risk of serious bleeding in the case of inadvertent vascular or cardiac perforations (<a href="./references#CD010196-bbs2-0016" title="BraunwaldE , GorlinR . Cooperative study on cardiac catheterization. Total population studied, procedures employed, and incidence of complications. Circulation1968;37(5 Suppl):iii8‐16. ">Braunwald 1968</a>; <a href="./references#CD010196-bbs2-0022" title="FormanekG , FrechRS , AmplatzK . Arterial thrombus formation during clinical percutaneous catheterization. Circulation1970;41(5):833‐9. ">Formanek 1970</a>). Soon afterwards systemic heparinization was introduced in pediatrics and now being part of daily current practice it has been responsible for the decline in the incidence of arterial thrombosis following CC (<a href="./references#CD010196-bbs2-0024" title="GirodDA , HurwitzRA , CaldwellRL . Heparinization for prevention of thrombosis following pediatric percutaneous arterial catheterization. Pediatric Cardiology1982;3(2):175‐80. ">Girod 1982</a>). </p> </section> <section id="CD010196-sec-0033"> <h3 class="title" id="CD010196-sec-0033">How the intervention might work</h3> <p>Unfractionated heparin, from now on referred to as heparin, is the oldest and the most widely utilized anticoagulant agent. It was listed as an essential drug in 1997 by the World Health Organization (<a href="./references#CD010196-bbs2-0063" title="WHO Expert Committee on the Use of Essential Drugs (‎1995: Geneva, Switzerland)‎ and World Health Organization. The use of essential drugs: seventh report of the WHO Expert Committee (including the revised model list of essential drugs). World Health Organization. https://apps.who.int/iris/handle/10665/41938 (accessed 18 December 2019). ">WHO 1997</a>). Its appeal derives from its very short half‐life and immediate reversibility in case of an emergency, making it suitable for patients in critical conditions requiring anticoagulation, or for patients undergoing procedures such as CC. </p> <p>The anticoagulant effect of heparin is mainly exerted by catalyzing thrombin and activated factor X inactivation. </p> </section> <section id="CD010196-sec-0034"> <h3 class="title" id="CD010196-sec-0034">Why it is important to do this review</h3> <p>The role of CC in pediatrics has progressed significantly over the last decades, evolving from a primary diagnostic tool to a primary treatment modality in children with congenital heart disease (<a href="./references#CD010196-bbs2-0064" title="WyszynskiD , GrahamT , Correa‐VillasenorA . Congenital heart defects: from origin to treatment. 1st Edition. USA: Oxford University Press, January 7, 2010. ">Wyszynski 2010</a>). Nevertheless, utilization of new technologies (that is larger sheaths and catheters) resulting in longer procedure times has contributed to a rise in the incidence of thromboembolic events (<a href="./references#CD010196-bbs2-0025" title="GlatzAC , ShahSS , McCarthyAL , GeisserD , DanielsK , XieD . Prevalence of and risk factors for acute occlusive arterial injury following pediatric cardiac catheterization: a large single‐center cohort study. Catheterization and Cardiovascular Interventions2013;82(3):454‐62. ">Glatz 2013</a>; <a href="./references#CD010196-bbs2-0027" title="GradyRM , EisenbergPR , BridgesND . Rational approach to use of heparin during cardiac catheterization in children. Journal of the American College of Cardiology1995;25(3):725‐9. ">Grady 1995</a>). Similarly, patient's weight (&lt; 4 kg; odds ratio (OR) 4.5, 95% confidence interval (CI) 2.6 to 7.7), anticoagulation effectiveness at the end of CC reflected by the automated clotting time (ACT) (ACT &lt; 250 sec; OR 1.9, 95% CI 1.4 to 2.7), and need for arterial catheter exchange during the procedure (OR 1.8, 95% CI 1.02 to 3.2) have also been implicated in the rise of post‐CC arterial occlusion (<a href="./references#CD010196-bbs2-0025" title="GlatzAC , ShahSS , McCarthyAL , GeisserD , DanielsK , XieD . Prevalence of and risk factors for acute occlusive arterial injury following pediatric cardiac catheterization: a large single‐center cohort study. Catheterization and Cardiovascular Interventions2013;82(3):454‐62. ">Glatz 2013</a>). Furthermore, vascular complication rates are reportedly three to six times higher in interventional procedures than in diagnostic procedures (<a href="./references#CD010196-bbs2-0035" title="InoT , BensonLN , FreedomRM , BarkerGA , AipurskyA , RoweRD . Thrombolytic therapy for femoral artery thrombosis after pediatric cardiac catheterization. American Heart Journal1988;115(3):633‐9. ">Ino 1988</a>), contributing to this increase. </p> <p>Congenital heart disease is one of the most common genetic abnormalities in children and is diagnosed in approximately 1% of all births. Severe conditions requiring specialized cardiologic support have been estimated to occur in 2.5 to 3 per 1000 live births (<a href="./references#CD010196-bbs2-0032" title="HoffmanJI , KaplanS . The incidence of congenital heart disease. Journal of the American College of Cardiology2002;39(12):1890‐900. ">Hoffman 2002</a>). In Canada alone, approximately 2000 children are born every year with congenital heart disease, many of whom will require several CCs throughout their childhood. As more children with complex congenital heart disease survive longer and require multiple catheterizations, preventing thrombotic events is paramount since this “can ultimately determine a child's future therapeutic options” (<a href="./references#CD010196-bbs2-0027" title="GradyRM , EisenbergPR , BridgesND . Rational approach to use of heparin during cardiac catheterization in children. Journal of the American College of Cardiology1995;25(3):725‐9. ">Grady 1995</a>). </p> <p>One of the strategies to lower the frequency of thrombotic complications during CC is the use of prophylactic systemic anticoagulation, which is administered immediately after arterial puncture. On the other hand the major complication associated with heparin is bleeding. In adult patients it has been reported that the incidence of bleeding complications associated with heparin may be influenced by the dose or the intensity of anticoagulation, as measured by laboratory tests evaluating hemostasis (<a href="./references#CD010196-bbs2-0041" title="LevineMN , RaskobG , LandefeldS , KearonC . Hemorrhagic complications of anticoagulant treatment. Chest2001;119(1 Suppl):108S‐21S. ">Levine 2001</a>). Consequently, the use of systemic heparinization for thrombosis prevention post‐CC is associated with a narrow therapeutic window, balancing protection against clots and bleeding. In spite of the widespread use of heparin during CC, the optimal dose has not yet been established (<a href="./references#CD010196-bbs2-0051" title="PriceV , MassicotteMP . Arterial thromboembolism in the pediatric population. Seminars in Thrombosis and Hemostasis2003;29(6):557‐65. ">Price 2003</a>). </p> <p>Current guidelines recommend the use of a single heparin dose of 100 units/kg administered as a bolus for catheters of either arterial or venous entry access (<a href="./references#CD010196-bbs2-0023" title="GigliaTM , MassicotteMP , TweddellJS , BarstRJ , BaumanM , EricksonCC , et al. American Heart Association Congenital Heart Defects Committee of the Council on Cardiovascular Disease in the Young, Council on Cardiovascular and Stroke Nursing, Council on Epidemiology and Prevention, and Stroke Council. Prevention and treatment of thrombosis in pediatric and congenital heart disease: a scientific statement from the American Heart Association. Circulation2013;128(4):2622‐703. ">Giglia 2013</a>; <a href="./references#CD010196-bbs2-0046" title="MonagleP , ChanAV , GoldenbergNA , IchordRN , JourneucakeJM , Nowak‐GöttleU , et al. American College of Chest Physicians. Antithrombotic therapy in neonates and children: Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence‐Based Clinical Practice Guidelines. Chest2012;141(2 Suppl):e737S‐801S. ">Monagle 2012</a>). This recommendation is rooted in a randomized trial conducted in 1974 which compared 100 to 150 units/kg of heparin to placebo (<a href="./references#CD010196-bbs2-0005" title="FreedMD , KeaneJ , RosenthalA . The use of heparinization to prevent arterial thrombosis after percutaneous cardiac catheterization in children. Circulation1974;50:565‐9. ">Freed 1974</a>), showing a lower incidence of thrombotic complications in the heparin group (8% versus 40%). Subsequent studies have continued using this relatively high dose. Bleeding complications have been described in approximately 7.5% to 8.5% of children undergoing CC with doses of heparin equal to or higher than 100 units/kg (<a href="./references#CD010196-bbs2-0043" title="MehtaR , LeeKJ , ChaturvediR , BensonL . Complications of pediatric cardiac catheterization: a review in the current era. Catheterization and Cardiovascular Interventions2008;72(2):278‐85. ">Mehta 2008</a>; <a href="./references#CD010196-bbs2-0058" title="VitielloR , McCrindleBW , NykanenD , FreedomRM , BensonLN . Complications associated with pediatric cardiac catheterization. Journal of the American College of Cardiology1998;32(5):1433‐40. ">Vitiello 1998</a>). It is noteworthy that a 50 unit/kg initial dose has also been utilized (<a href="./references#CD010196-bbs2-0038" title="KulkarniS , NaiduR . Vascular ultrasound imaging to study immediate post catheterization vascular complications in children. Catheterization and Cardiovascular Interventions2006;68(3):450‐5. ">Kulkarni 2006</a>). Nonetheless, little is known about bleeding rates and laboratory alterations following the administration of distinct heparin doses in children undergoing CC (<a href="./references#CD010196-bbs2-0019" title="ChenD , LångströmS , PetäjäJ , HeikinheimoM , PihkalaJ . Thrombin formation and effect of unfractionated heparin during pediatric cardiac catheterization. Catheterization and Cardiovascular Interventions2013;81(7):1174‐9. ">Chen 2013</a>; <a href="./references#CD010196-bbs2-0036" title="KimGG , ElRoubyS , ThompsonJ , GuptaA , WilliamsJ , JobesDR . Monitoring unfractionated heparin in pediatric patients with congenital heart disease having cardiac catheterization or cardiac surgery. Journal of Thrombosis and Thrombolysis2010;29(4):429‐36. ">Kim 2010</a>; <a href="./references#CD010196-bbs2-0049" title="NewallF , IgnjatovicV , JohnstonL , SummerhayesR , LaneG , CranswickN , et al. Age is a determinant factor for measures of concentration and effect in children requiring unfractionated heparin. Thrombosis and Haemostasis2010;103(5):1085‐90. ">Newall 2010</a>). Given the high volume of procedures and their related morbidity, either related to thrombotic or to bleeding complications, it is vital to titrate the dosing of anticoagulation prophylaxis to an optimal level that guarantees both efficacy and safety. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD010196-sec-0035" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD010196-sec-0035"></div> <p>To evaluate the use of low‐dose (&lt; 100 units/kg) versus high‐dose (≥ 100 units/kg) unfractionated heparin administered as an intravenous bolus at the time of initiation of cardiac catheterization (that is, immediately after arterial puncture), with or without subsequent heparin maintenance doses, for the prevention of post‐procedural arterial thrombosis in children. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD010196-sec-0036" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD010196-sec-0036"></div> <section id="CD010196-sec-0037"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD010196-sec-0038"> <h4 class="title">Types of studies</h4> <p>We included randomized and quasi‐randomized controlled trials that compared peri‐procedural prophylactic regimens of unfractionated heparin (UFH) administration in children undergoing cardiac catheterization (CC). </p> </section> <section id="CD010196-sec-0039"> <h4 class="title">Types of participants</h4> <p>We included all studies conducted in children aged 0 to 18 years undergoing CC. Studies conducted primarily in adults and only including a few adolescents were therefore excluded. When patients older than 18 years of age were included, we considered only those studies with a median or mean age &lt; 10 years, since these studies include a majority of pediatric patients. </p> </section> <section id="CD010196-sec-0040"> <h4 class="title">Types of interventions</h4> <p>We included studies in which two or more different UFH doses administered at the time of initiation of CC (immediately after arterial puncture) were compared. The studies had to involve a low UFH dose arm, defined as &lt; 100 units/kg, and a high UFH dose arm, defined as ≥ 100 units/kg. The cut‐off points were taken from current pediatric guidelines, which recommend the use of heparin doses of 100 units/kg administered as a bolus, compared with lower doses of heparin (50 units/kg) (<a href="./references#CD010196-bbs2-0023" title="GigliaTM , MassicotteMP , TweddellJS , BarstRJ , BaumanM , EricksonCC , et al. American Heart Association Congenital Heart Defects Committee of the Council on Cardiovascular Disease in the Young, Council on Cardiovascular and Stroke Nursing, Council on Epidemiology and Prevention, and Stroke Council. Prevention and treatment of thrombosis in pediatric and congenital heart disease: a scientific statement from the American Heart Association. Circulation2013;128(4):2622‐703. ">Giglia 2013</a>; <a href="./references#CD010196-bbs2-0046" title="MonagleP , ChanAV , GoldenbergNA , IchordRN , JourneucakeJM , Nowak‐GöttleU , et al. American College of Chest Physicians. Antithrombotic therapy in neonates and children: Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence‐Based Clinical Practice Guidelines. Chest2012;141(2 Suppl):e737S‐801S. ">Monagle 2012</a>). Even though the initial heparin doses were the main focus of the study, the use of subsequent maintenance doses was also registered. </p> </section> <section id="CD010196-sec-0041"> <h4 class="title">Types of outcome measures</h4> <section id="CD010196-sec-0042"> <h5 class="title">Primary outcomes</h5> <p> <ul id="CD010196-list-0001"> <li> <p>Arterial thrombotic events</p> </li> </ul> </p> <p>Symptomatic or asymptomatic events of arterial thrombosis diagnosed during the immediate post‐procedural period following CC (first 48 hours). Clinical findings (decreased pulses lasting more than six hours after the procedure) or imaging studies (doppler ultrasound or arteriography), or both, were acceptable methods for the diagnosis of arterial thrombosis. Although clinical suspicion is not considered the gold standard method for detection of thrombus, it remains a widely accepted method for assessment of obstruction of a blood vessel in this clinical setting. </p> <p> <ul id="CD010196-list-0002"> <li> <p>Major bleeding events</p> </li> </ul> </p> <p>Major bleeding events were defined as one or more of the following (adapted from <a href="./references#CD010196-bbs2-0054" title="SchulmanS , AngeråsU , BergqvistD , ErikssonB , LassenMR , FisherW , subcommittee on control of anticoagulation of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patients. Journal of Thrombosis and Haemostasis2010;8(1):202‐4. ">Schulman 2010</a> and <a href="./references#CD010196-bbs2-0044" title="MitchellLG , GoldenbergNA , MaleC , KenetG , MonagleP , Nowak‐GöttlU , on behalf of the perinatal and paediatric haemostasis subcommittee of the SSC of the ISTH. Definition of clinical efficacy and safety outcomes for clinical trials in deep venous thrombosis and pulmonary embolism in children. Journal of Thrombosis and Haemostasis2011;9(9):1856‐8. ">Mitchell 2011</a>): </p> <p> <ul class="plain" id="CD010196-list-0003"> <li> <ul id="CD010196-list-0004"> <li> <p>fatal bleeding;</p> </li> <li> <p>bleeding that is symptomatic and occurs in a critical area or organ (such as intracranial, intraspinal, intraocular, retroperitoneal, pericardial, in a non‐operated joint, or intramuscular with compartment syndrome), assessed in consultation with the surgeon; </p> </li> <li> <p>extrasurgical site bleeding causing a fall in hemoglobin level of 20 g/L (1.24 mmol/L) or more, or leading to transfusion of whole blood or red cells with a temporal association within 24 to 48 h of the bleeding; </p> </li> <li> <p>surgical site bleeding that requires a second intervention (open, arthroscopic, endovascular) or a hemarthrosis of sufficient size as to interfere with rehabilitation by delaying mobilization or causing delayed wound healing, resulting in prolonged hospitalization or a deep wound infection; </p> </li> <li> <p>surgical site bleeding that is unexpected and prolonged or sufficiently large to cause hemodynamic instability, as assessed by the surgeon. There should be an associated fall in the hemoglobin level of at least 20 g/L (1.24 mmol/L), or a transfusion indicated by the bleeding with a temporal association within 24 h of the bleeding. </p> </li> </ul> </li> </ul> <ul id="CD010196-list-0005"> <li> <p>Minor bleeding events: overt or macroscopic evidence of bleeding not encompassed in the above definition for major bleeding </p> </li> </ul> </p> <p>The period for collection of these data was from the start of the procedure until five half‐lives after the last dose of the UFH (that is, approximately 2.5 to 5 hours depending on the dose). </p> </section> <section id="CD010196-sec-0043"> <h5 class="title">Secondary outcomes</h5> <p> <ul id="CD010196-list-0006"> <li> <p>Other thrombotic events: venous thrombosis and thrombosis in implanted devices</p> </li> <li> <p>Other side effects of heparin:</p> <ul id="CD010196-list-0007"> <li> <p>incidence of heparin induced thrombocytopenia (HIT), as per the definition of the included studies. Ideally, the definition of HIT should combine consistent clinical findings (thrombocytopenia occurring five to 14 days after initiation of heparin exposure, or sooner in cases with prior heparin exposure, with or without thrombosis) and laboratory assessment for HIT antibodies (platelet‐activating antibodies tested with functional assays, with or without additional antigen assays). These criteria have been extrapolated from those of adult patients (<a href="./references#CD010196-bbs2-0062" title="WarkentinTE . New approaches to the diagnosis of heparin‐induced thrombocytopenia. Chest2005;127(2 Suppl):35S‐45S. ">Warkentin 2005</a>); </p> </li> <li> <p>anaphylaxis, as per the definition of the included studies;</p> </li> <li> <p>skin necrosis, as per the definition of the included studies.</p> </li> </ul> </li> </ul> </p> </section> </section> </section> <section id="CD010196-sec-0044"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD010196-sec-0045"> <h4 class="title">Electronic searches</h4> <p>The Cochrane Vascular Information Specialist conducted systematic searches of the following databases for randomized controlled trials and controlled clinical trials without language, publication year or publication status restrictions: </p> <p> <ul id="CD010196-list-0008"> <li> <p>the Cochrane Vascular Specialised Register via the Cochrane Register of Studies (CRS‐Web searched on 16 October 2019); </p> </li> <li> <p>the Cochrane Central Register of Controlled Trials (CENTRAL) Cochrane Register of Studies Online (CRSO 2019, Issue 8); </p> </li> <li> <p>MEDLINE (Ovid MEDLINE® Epub Ahead of Print, In‐Process &amp; Other Non‐Indexed Citations, Ovid MEDLINE® Daily and Ovid MEDLINE®) (searched from 1 January 2017 to 16 October 2019); </p> </li> <li> <p>Embase Ovid (searched from 1 January 2017 to 16 October 2019);</p> </li> <li> <p>CINAHL Ebsco (searched from 1 January 2017 to 16 October 2019);</p> </li> <li> <p>AMED Ovid (searched from 1 January 2017 to 16 October 2019).</p> </li> </ul> </p> <p>The Information Specialist modelled search strategies for other databases on the search strategy designed for CENTRAL. Where appropriate, they were combined with adaptations of the highly sensitive search strategy designed by the Cochrane Collaboration for identifying randomized controlled trials and controlled clinical trials (as described in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> Chapter 6, <a href="./references#CD010196-bbs2-0039" title="LefebvreC , ManheimerE , GlanvilleJ . Chapter 6: Searching for studies. In: Higgins JP, Green S editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration. Available from handbook.cochrane.org. ">Lefebvre 2011</a>). Search strategies for major databases are provided in <a href="./appendices#CD010196-sec-0098">Appendix 1</a>. </p> <p>The Information Specialist searched the following trials registries on 16 October 2019: </p> <p> <ul id="CD010196-list-0009"> <li> <p>the World Health Organization International Clinical Trials Registry Platform (<a href="http://who.int/trialsearch" target="_blank">who.int/trialsearch</a>); </p> </li> <li> <p>ClinicalTrials.gov (<a href="http://clinicaltrials.gov" target="_blank">clinicaltrials.gov</a>). </p> </li> </ul> </p> </section> <section id="CD010196-sec-0046"> <h4 class="title">Searching other resources</h4> <p>We planned to undertake reference checking of identified trials to identify additional studies. </p> </section> </section> <section id="CD010196-sec-0047"> <h3 class="title" id="CD010196-sec-0047">Data collection and analysis</h3> <section id="CD010196-sec-0048"> <h4 class="title">Selection of studies</h4> <p>One of the authors (MLA) reviewed and evaluated the titles and abstracts of the articles retrieved during the searches to identify and exclude irrelevant studies. All articles that met the eligibility criteria based on the first screening were assessed independently by two review authors (MLA, LRB). The authors discussed and resolved disagreements by consensus. </p> </section> <section id="CD010196-sec-0049"> <h4 class="title">Data extraction and management</h4> <p>We created a specific electronic data collection form, which was used for data extraction. Two authors (MLA, LRB) individually and independently extracted data from the eligible studies. The authors discussed and resolved disagreements and consulted the third author (PSS) whenever required. Study investigators were contacted in order to retrieve full information not found in the original publications. </p> </section> <section id="CD010196-sec-0050"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>We assessed the risk of bias in the included studies following the Cochrane 'Risk of bias' tool (<a href="./references#CD010196-bbs2-0029" title="HigginsJP , AltmanDG , editor(s) . Chapter 8: Assessing risk of bias in included studies. In: HigginsJP , GreenS editor(s). Cochrane Handbook for Systematic Reviews of Interventions. Chichester (UK): John Wiley &amp; Sons, 2008:187‐241. ">Higgins 2008a</a>). Two authors independently performed this evaluation (MLA, LRB), discussing any disagreements to reach a consensus. </p> <p>The following domains at risk of bias were assessed and reported for individual studies (<a href="./references#CD010196-bbs2-0029" title="HigginsJP , AltmanDG , editor(s) . Chapter 8: Assessing risk of bias in included studies. In: HigginsJP , GreenS editor(s). Cochrane Handbook for Systematic Reviews of Interventions. Chichester (UK): John Wiley &amp; Sons, 2008:187‐241. ">Higgins 2008a</a>). </p> <section id="CD010196-sec-0051"> <h5 class="title">Selection bias (random sequence generation and allocation concealment)</h5> <p>For each included study, we categorized the risk of selection bias as follows.</p> <section id="CD010196-sec-0052"> <h6 class="title">Random sequence generation</h6> <p> <ul id="CD010196-list-0010"> <li> <p>Low risk ‐ adequate (any truly random process e.g., random number table; computer random number generator) </p> </li> <li> <p>High risk ‐ inadequate (any non‐random process e.g., odd or even date of birth; hospital or clinic record number) </p> </li> <li> <p>Unclear risk ‐ no or unclear information provided</p> </li> </ul> </p> </section> <section id="CD010196-sec-0053"> <h6 class="title">Allocation concealment</h6> <p> <ul id="CD010196-list-0011"> <li> <p>Low risk ‐ adequate (e.g., telephone or central randomisation; consecutively numbered sealed opaque envelopes) </p> </li> <li> <p>High risk ‐ inadequate (open random allocation; unsealed or non‐opaque envelopes, alternation; date of birth) </p> </li> <li> <p>Unclear risk ‐ no or unclear information provided</p> </li> </ul> </p> </section> </section> <section id="CD010196-sec-0054"> <h5 class="title">Performance bias</h5> <p>For each included study, we categorized the methods used to blind study personnel from knowledge of which intervention a participant received. </p> <p> <ul id="CD010196-list-0012"> <li> <p>Low risk ‐ adequate for personnel (a placebo that could not be distinguished from the active drug was used in the control group) </p> </li> <li> <p>High risk ‐ inadequate, personnel aware of group assignment</p> </li> <li> <p>Unclear risk ‐ no or unclear information provided</p> </li> </ul> </p> </section> <section id="CD010196-sec-0055"> <h5 class="title">Detection bias</h5> <p>For each included study, we categorized the methods used to blind outcome assessors from knowledge of which intervention a participant received. Blinding was assessed separately for different outcomes or classes of outcomes. We categorized the methods used with regards to detection bias as follows. </p> <p> <ul id="CD010196-list-0013"> <li> <p>Low risk ‐ adequate, follow‐up was performed with assessors blinded to group assignment.</p> </li> <li> <p>High risk ‐ inadequate, assessors at follow‐up were aware of group assignment.</p> </li> <li> <p>Unclear risk ‐ no or unclear information provided.</p> </li> </ul> </p> </section> <section id="CD010196-sec-0056"> <h5 class="title">Attrition bias</h5> <p>For each included study, and for each outcome, we described the completeness of data including attrition and exclusions from the analysis. We noted whether attrition and exclusions were reported, the numbers included in the analysis at each stage (compared with the total number of randomized participants), reasons for attrition or exclusion where reported, and whether missing data were balanced across groups or were related to outcomes. We categorized the methods with respect to the risk of attrition bias as follows. </p> <p> <ul id="CD010196-list-0014"> <li> <p>Low risk ‐ adequate (&lt; 10% missing data).</p> </li> <li> <p>High risk ‐ inadequate (&gt; 10% missing data).</p> </li> <li> <p>Unclear risk ‐ no or unclear information provided.</p> </li> </ul> </p> </section> <section id="CD010196-sec-0057"> <h5 class="title">Reporting bias</h5> <p>For each included study, we described how we investigated the risk of selective outcome reporting bias and what we found. We assessed the methods as follows. </p> <p> <ul id="CD010196-list-0015"> <li> <p>Low risk ‐ adequate (where it is clear that all of the study's pre‐specified outcomes and all expected outcomes of interest to the review have been reported). </p> </li> <li> <p>High risk ‐ inadequate (where not all the study's pre‐specified outcomes have been reported; one or more reported primary outcomes were not pre‐specified; outcomes of interest are reported incompletely and so cannot be used; study fails to include results of a key outcome that would have been expected to have been reported). </p> </li> <li> <p>Unclear risk ‐ no or unclear information provided (the study protocol was not available).</p> </li> </ul> </p> </section> <section id="CD010196-sec-0058"> <h5 class="title">Other bias</h5> <p>For each included study, we described any important concerns we had about other possible sources of bias (for example, whether there was a potential source of bias related to the specific study design or whether the trial was stopped early due to some data‐dependent process). We assessed whether each study was free of other problems that could put it at risk of bias as follows. </p> <p> <ul id="CD010196-list-0016"> <li> <p>Low risk ‐ no concerns of other bias.</p> </li> <li> <p>High risk ‐ concerns about multiple looks at the data with the results made known to the investigators; difference in number of patients enrolled in abstract and final publications of the paper. </p> </li> <li> <p>Unclear ‐ concerns about potential sources of bias that could not be verified by contacting the authors. </p> </li> </ul> </p> </section> </section> <section id="CD010196-sec-0059"> <h4 class="title">Measures of treatment effect</h4> <p>We analyzed thrombotic events and complications associated with heparin as dichotomous outcomes. The effect measures used were risk ratio (RR), risk difference (RD) and number needed to treat (NNT), with 95% CIs. </p> </section> <section id="CD010196-sec-0060"> <h4 class="title">Dealing with missing data</h4> <p>We used the information available from the studies when we considered dropouts to be missing at random (independent of the observed data and the missing data, or dependent on the observed data but independent of the missing data). Though the use of available data only could potentially lead to bias, this practice is commonly used in meta‐analyses and provides a sensible starting point (<a href="./references#CD010196-bbs2-0030" title="HigginsJP , DeeksJJ , AltmanDG , editor(s) . Chapter 16: Special topics in statistics. In: HigginsJP , GreenS editor(s). Cochrane Handbook for Systematic Reviews of Interventions. Chichester (UK): John Wiley &amp; Sons, 2008:481‐529. ">Higgins 2008b</a>; <a href="./references#CD010196-bbs2-0031" title="HigginsJP , WhiteIR , WoodAM . Imputation methods for missing outcome data in meta‐analysis of clinical trials. Clinical Trials2008;5(3):225‐39. ">Higgins 2008c</a>). We planned to conduct a sensitivity analysis using studies with data suspected not to be missing at random. </p> </section> <section id="CD010196-sec-0061"> <h4 class="title">Assessment of heterogeneity</h4> <p>We used the Chi<sup>2</sup> test of homogeneity, with the significance threshold set at P &lt; 0.10, to detect statistically significant heterogeneity. In addition, we investigated the degree of heterogeneity by calculating the I<sup>2</sup> statistic (<a href="./references#CD010196-bbs2-0030" title="HigginsJP , DeeksJJ , AltmanDG , editor(s) . Chapter 16: Special topics in statistics. In: HigginsJP , GreenS editor(s). Cochrane Handbook for Systematic Reviews of Interventions. Chichester (UK): John Wiley &amp; Sons, 2008:481‐529. ">Higgins 2008b</a>). </p> </section> <section id="CD010196-sec-0062"> <h4 class="title">Assessment of reporting biases</h4> <p>We did not investigate publication bias using funnel plots since the number of studies identified was small (that is, less than 10 studies). We intend to do this for future updates if more studies are identified. </p> </section> <section id="CD010196-sec-0063"> <h4 class="title">Data synthesis</h4> <p>We used Review Manager software (<a href="./references#CD010196-bbs2-0052" title="Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">Review Manager 2014</a>) to perform data analysis. We estimated the RR, RD, NNT either to benefit (NNTB) or harm (NNTH) (<a href="./references#CD010196-bbs2-0011" title="AltmanD . Confidence intervals for the number needed to treat. BMJ1998;317(7168):1309‐12. ">Altman 1998</a>) for the outcomes when appropriate; the 95% CI was calculated for each estimate. We used a random‐effects model based on the inverse variance approach for our analysis. </p> </section> <section id="CD010196-sec-0064"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We planned to stratify the analysis according to the patients' ages at the time of the procedure (older or younger than one year), weight (above or below 10 kg), type of procedure (intervention versus diagnostic), and any other possible sources of heterogeneity (such as duration of procedure, subsequent heparin dosing, activated partial thromboplastin time (aPTT) or antifactor Xa (anti‐Xa) levels achieved during the procedure). It is hypothesized that younger patients and patients with weight below 10 kg may be at higher risk of thrombotic events due to the small caliber of their vasculature in relation to the size of the instruments used for CC. Similarly, interventional procedures may require relatively larger instruments, thus portending a higher risk of thrombosis. Due to unavailability of data we were unable to conduct subgroup analysis in this version of the review. </p> </section> <section id="CD010196-sec-0065"> <h4 class="title">Sensitivity analysis</h4> <p>We planned to perform a sensitivity analysis by excluding low quality studies but, given the small number of studies included, it was not possible to conduct such an analysis. </p> <section id="CD010196-sec-0066"> <h5 class="title">Summary of findings and assessment of the certainty of the evidence</h5> <p>We prepared a 'Summary of findings' (SOF) table to present the findings from the review comparing low dose UFH with high dose UFH in children with congenital heart disease. We included the outcomes of thrombotic events, major bleeding, minor bleeding, venous thrombosis and adverse events. See <a href="./full#CD010196-tbl-0001">summary of findings Table for the main comparison</a>. </p> <p>We used GRADEprofiler software to create the table (<a href="./references#CD010196-bbs2-0026" title="McMaster University (developed by Evidence Prime). GRADEpro GDT. Version (accessed 18 December 2019). Hamilton, ON: McMaster University (developed by Evidence Prime), 2015. ">GRADEpro GDT 2015</a>). We used the GRADE criteria to rank the certainty of the evidence for each outcome based on risk of bias, inconsistency, indirectness, imprecision and publication bias (<a href="./references#CD010196-bbs2-0028" title="GuyattGH , OxmanAD , VistGE , KunzR , Falck‐YtterY , Alonso‐CoelloP , et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ2008;336(7650):924‐6. ">Guyatt 2008</a>). We have provided a description for each step to downgrade the certainty of the evidence. </p> </section> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD010196-sec-0067" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD010196-sec-0067"></div> <section id="CD010196-sec-0068"> <h3 class="title">Description of studies</h3> <section id="CD010196-sec-0069"> <h4 class="title">Results of the search</h4> <p>See <a href="#CD010196-fig-0001">Figure 1</a>, which shows the study selection flowchart. For this update, we did not identify any new included studies. We identified two new excluded studies (<a href="./references#CD010196-bbs2-0006" title="NCT02767232 . Pediatric high‐risk deep venous thrombosis lytic outcomes trial. clinicaltrials.gov/ct2/show/NCT02767232 (first posted 12 May 2016). ">NCT02767232</a>; <a href="./references#CD010196-bbs2-0007" title="NCT03894904 . Papaverine vs heparin for peripheral arterial catheter patency in pediatric patients. clinicaltrials.gov/ct2/show/NCT03894904 (first posted 29 March 2019). ">NCT03894904</a>). </p> <div class="figure" id="CD010196-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD010196-fig-0001" src="/cdsr/doi/10.1002/14651858.CD010196.pub3/media/CDSR/CD010196/image_n/nCD010196-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> </section> <section id="CD010196-sec-0070"> <h4 class="title">Included studies</h4> <p>We did not identify any new studies for inclusion for this update. Therefore. two studies with a total of 492 participants were included in the review. </p> <p>One of the studies (<a href="./references#CD010196-bbs2-0001" title="EUCTR2005‐004150‐27‐AT . Randomized controlled trial comparing two heparinization protocols for prophylaxis of short‐ and long‐term thrombotic complications of pediatric cardiac catheterization the HEARTCAT‐Study (HEparin Anticoagulation Randomised Trial for Cardiac Catheterization). apps.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2005‐004150‐27‐AT (first posted 12 December 2005). HanslikA , KitzmullerE , HaumerM , KarapetianH , ThomK , Salzer‐MuharU , et al. Incidence of thrombotic and bleeding complications during cardiac catheterization in children (HEARTCAT‐study). Journal of Thrombosis and Haemostasis2009;7(Suppl 2):465. HanslikA , KitzmullerE , Mlekusch , W , Salzer‐MuharU , Michel‐BehnkeI , MaleC . Randomized controlled trial comparing two heparinization protocols for prophylaxis of vascular thrombosis during cardiac catheterization in children ‐ the HEARTCAT study. Cardiology in the Young. Conference: 44th Annual Meeting of the Association for European Paediatric Cardiology, AEPC with Joint Sessions with the Japanese Society of Pediatric Cardiology and Cardiac Surgery Innsbruck Austria. 2010; Vol. 20:S39. HanslikA , KitzmullerE , ThomK , HaumerM , MlekuschW , Salzer‐MuharU , et al. Incidence of thrombotic and bleeding complications during cardiac catheterization in children: comparison of high‐dose versus low‐dose heparin protocols. Journal of Thrombosis and Haemostasis2011;9(12):2353‐60. Hanslik , A , Kitzmüller , E , Thom , K , Haumer , M , Salzer‐Muhar , U , Michel‐Behnke , I , Male , C . Comparison of high‐dose versus low‐dose heparinization protocols for prophylaxis of thrombotic complications during cardiac catheterization in children (HEARTCAT study). Hamostaseologie2010;30(1):A14. KitzmullerE , HanslikA , KarapetianH , Salzer‐MuharU , Michel‐BehnkeI , MaleC . Monitoring unfractionated heparin during cardiac catheterization in children – results from the HEARTCAT study. Cardiology in the Young. Conference: 44th Annual Meeting of the Association for European Paediatric Cardiology, AEPC with Joint Sessions with the Japanese Society of Pediatric Cardiology and Cardiac Surgery Innsbruck Austria. 2010; Vol. 20:s95. ">Hanslik 2011</a>) randomized 137 patients aged 0 to 19 years (median 5.6 years, 23% infants) to receive either a high dose of heparin (100 units/kg), followed by a continuous infusion of therapeutic doses of heparin, or a low dose of heparin consisting of a bolus of 50 units/kg at the time of vascular access, and an additional bolus of 50 units/kg every two hours during the procedure. Pre‐ and post‐procedural assessment of arterial thrombosis was done using Doppler ultrasound (US). Additionally, clinical assessment was recorded. </p> <p>The second study (<a href="./references#CD010196-bbs2-0002" title="SaxenaA , GuptaR , KumarRK , KothariSS , WasirHS . Predictors of arterial thrombosis after diagnostic cardiac catheterization in infants and children randomized to two heparin dosages. Catheterization and Cardiovascular Diagnosis1997;41(4):400‐3. ">Saxena 1997</a>) included 366 patients aged 17 days to 11 years (mean 39.5 months, 24.9% infants). Patients were randomized to receive 50 units/kg or 100 units/kg of heparin as a single bolus administered immediately after arterial puncture. Assessment of arterial thrombosis was done by clinical examination only. </p> <p>For further details of the included studies, please refer to <a href="./references#CD010196-sec-0108" title="">Characteristics of included studies</a>. </p> </section> <section id="CD010196-sec-0071"> <h4 class="title">Excluded studies</h4> <p>Please refer to <a href="./references#CD010196-sec-0109" title="">Characteristics of excluded studies</a> for details. </p> <p>Two new studies were excluded for this update (<a href="./references#CD010196-bbs2-0006" title="NCT02767232 . Pediatric high‐risk deep venous thrombosis lytic outcomes trial. clinicaltrials.gov/ct2/show/NCT02767232 (first posted 12 May 2016). ">NCT02767232</a>; <a href="./references#CD010196-bbs2-0007" title="NCT03894904 . Papaverine vs heparin for peripheral arterial catheter patency in pediatric patients. clinicaltrials.gov/ct2/show/NCT03894904 (first posted 29 March 2019). ">NCT03894904</a>), bringing the total to seven RCTs excluded. Studies were excluded for the following reasons: </p> <p> <ul id="CD010196-list-0017"> <li> <p>setting and outcome not matching those of our review (<a href="./references#CD010196-bbs2-0004" title="Butt W , ShannF , McDonnellG , HudsonI . Effect of heparin concentration and infusion rate on the patency of arterial catheters. Critical Care Medicine1987;15(3):230‐2. ">Butt 1987</a>; <a href="./references#CD010196-bbs2-0006" title="NCT02767232 . Pediatric high‐risk deep venous thrombosis lytic outcomes trial. clinicaltrials.gov/ct2/show/NCT02767232 (first posted 12 May 2016). ">NCT02767232</a>; <a href="./references#CD010196-bbs2-0007" title="NCT03894904 . Papaverine vs heparin for peripheral arterial catheter patency in pediatric patients. clinicaltrials.gov/ct2/show/NCT03894904 (first posted 29 March 2019). ">NCT03894904</a>); </p> </li> <li> <p>heparin not prophylactically administered (<a href="./references#CD010196-bbs2-0008" title="RaoPS , ThaparMK , RogersJHJr , StrongWB , LutcherCL , NesbitRRJr , et al. Effect of intraarterial injection of heparin on the complications of percutaneous arterial catheterization in infants and children. Catheterization and Cardiovascular Diagnosis1981;7(3):235‐46. ">Rao 1981</a>; <a href="./references#CD010196-bbs2-0009" title="SchroederAR , AxelrodDM , SilvermanNH , RubesovaE , MerkelE , RothSJ . A continuous heparin infusion does not prevent catheter‐related thrombosis in infants after cardiac surgery. Pediatric Critical Care Medicine2010;11(4):489‐95. ">Schroeder 2010</a>); </p> </li> <li> <p>not relevant comparisons, such as heparin versus normal saline (<a href="./references#CD010196-bbs2-0005" title="FreedMD , KeaneJ , RosenthalA . The use of heparinization to prevent arterial thrombosis after percutaneous cardiac catheterization in children. Circulation1974;50:565‐9. ">Freed 1974</a>) and heparin in high doses only (<a href="./references#CD010196-bbs2-0003" title="BulbulZR , GalalMO , MahmoudE , NardenB , SolymarL , ChaudharyMA , et al. Arterial complications following cardiac catheterization in children less than 10 kg. Asian Cardiovascular and Thoracic Annals2002;10(2):129‐32. BulbulZR , GalalO , Al FadleyF , JufanMA , AlOS . Arterial complications following cardiac catheterization in children &lt; 10 kg. Randomized to two heparin dosages: a prospective double blinded study. Journal of the Saudi Heart Association2001;13(1):52. ">Bulbul 2002</a>). </p> </li> </ul> </p> </section> </section> <section id="CD010196-sec-0072"> <h3 class="title">Risk of bias in included studies</h3> <p>Please see the <a href="#CD010196-fig-0002">Figure 2</a> and <a href="#CD010196-fig-0003">Figure 3</a>. </p> <div class="figure" id="CD010196-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD010196-fig-0002" src="/cdsr/doi/10.1002/14651858.CD010196.pub3/media/CDSR/CD010196/image_n/nCD010196-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <div class="figure" id="CD010196-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD010196-fig-0003" src="/cdsr/doi/10.1002/14651858.CD010196.pub3/media/CDSR/CD010196/image_n/nCD010196-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <p>We assessed the risk of bias for all domains in <a href="./references#CD010196-bbs2-0001" title="EUCTR2005‐004150‐27‐AT . Randomized controlled trial comparing two heparinization protocols for prophylaxis of short‐ and long‐term thrombotic complications of pediatric cardiac catheterization the HEARTCAT‐Study (HEparin Anticoagulation Randomised Trial for Cardiac Catheterization). apps.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2005‐004150‐27‐AT (first posted 12 December 2005). HanslikA , KitzmullerE , HaumerM , KarapetianH , ThomK , Salzer‐MuharU , et al. Incidence of thrombotic and bleeding complications during cardiac catheterization in children (HEARTCAT‐study). Journal of Thrombosis and Haemostasis2009;7(Suppl 2):465. HanslikA , KitzmullerE , Mlekusch , W , Salzer‐MuharU , Michel‐BehnkeI , MaleC . Randomized controlled trial comparing two heparinization protocols for prophylaxis of vascular thrombosis during cardiac catheterization in children ‐ the HEARTCAT study. Cardiology in the Young. Conference: 44th Annual Meeting of the Association for European Paediatric Cardiology, AEPC with Joint Sessions with the Japanese Society of Pediatric Cardiology and Cardiac Surgery Innsbruck Austria. 2010; Vol. 20:S39. HanslikA , KitzmullerE , ThomK , HaumerM , MlekuschW , Salzer‐MuharU , et al. Incidence of thrombotic and bleeding complications during cardiac catheterization in children: comparison of high‐dose versus low‐dose heparin protocols. Journal of Thrombosis and Haemostasis2011;9(12):2353‐60. Hanslik , A , Kitzmüller , E , Thom , K , Haumer , M , Salzer‐Muhar , U , Michel‐Behnke , I , Male , C . Comparison of high‐dose versus low‐dose heparinization protocols for prophylaxis of thrombotic complications during cardiac catheterization in children (HEARTCAT study). Hamostaseologie2010;30(1):A14. KitzmullerE , HanslikA , KarapetianH , Salzer‐MuharU , Michel‐BehnkeI , MaleC . Monitoring unfractionated heparin during cardiac catheterization in children – results from the HEARTCAT study. Cardiology in the Young. Conference: 44th Annual Meeting of the Association for European Paediatric Cardiology, AEPC with Joint Sessions with the Japanese Society of Pediatric Cardiology and Cardiac Surgery Innsbruck Austria. 2010; Vol. 20:s95. ">Hanslik 2011</a> as low; and unclear for <a href="./references#CD010196-bbs2-0002" title="SaxenaA , GuptaR , KumarRK , KothariSS , WasirHS . Predictors of arterial thrombosis after diagnostic cardiac catheterization in infants and children randomized to two heparin dosages. Catheterization and Cardiovascular Diagnosis1997;41(4):400‐3. ">Saxena 1997</a>, except for random sequence generation, incomplete outcome reporting and other sources of bias (low risk of bias). </p> <section id="CD010196-sec-0073"> <h4 class="title">Allocation</h4> <p>Randomization sequences were generated by an independent statistician, using a computer, in <a href="./references#CD010196-bbs2-0001" title="EUCTR2005‐004150‐27‐AT . Randomized controlled trial comparing two heparinization protocols for prophylaxis of short‐ and long‐term thrombotic complications of pediatric cardiac catheterization the HEARTCAT‐Study (HEparin Anticoagulation Randomised Trial for Cardiac Catheterization). apps.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2005‐004150‐27‐AT (first posted 12 December 2005). HanslikA , KitzmullerE , HaumerM , KarapetianH , ThomK , Salzer‐MuharU , et al. Incidence of thrombotic and bleeding complications during cardiac catheterization in children (HEARTCAT‐study). Journal of Thrombosis and Haemostasis2009;7(Suppl 2):465. HanslikA , KitzmullerE , Mlekusch , W , Salzer‐MuharU , Michel‐BehnkeI , MaleC . Randomized controlled trial comparing two heparinization protocols for prophylaxis of vascular thrombosis during cardiac catheterization in children ‐ the HEARTCAT study. Cardiology in the Young. Conference: 44th Annual Meeting of the Association for European Paediatric Cardiology, AEPC with Joint Sessions with the Japanese Society of Pediatric Cardiology and Cardiac Surgery Innsbruck Austria. 2010; Vol. 20:S39. HanslikA , KitzmullerE , ThomK , HaumerM , MlekuschW , Salzer‐MuharU , et al. Incidence of thrombotic and bleeding complications during cardiac catheterization in children: comparison of high‐dose versus low‐dose heparin protocols. Journal of Thrombosis and Haemostasis2011;9(12):2353‐60. Hanslik , A , Kitzmüller , E , Thom , K , Haumer , M , Salzer‐Muhar , U , Michel‐Behnke , I , Male , C . Comparison of high‐dose versus low‐dose heparinization protocols for prophylaxis of thrombotic complications during cardiac catheterization in children (HEARTCAT study). Hamostaseologie2010;30(1):A14. KitzmullerE , HanslikA , KarapetianH , Salzer‐MuharU , Michel‐BehnkeI , MaleC . Monitoring unfractionated heparin during cardiac catheterization in children – results from the HEARTCAT study. Cardiology in the Young. Conference: 44th Annual Meeting of the Association for European Paediatric Cardiology, AEPC with Joint Sessions with the Japanese Society of Pediatric Cardiology and Cardiac Surgery Innsbruck Austria. 2010; Vol. 20:s95. ">Hanslik 2011</a> so this was at low risk of bias. Random numbers were used in <a href="./references#CD010196-bbs2-0002" title="SaxenaA , GuptaR , KumarRK , KothariSS , WasirHS . Predictors of arterial thrombosis after diagnostic cardiac catheterization in infants and children randomized to two heparin dosages. Catheterization and Cardiovascular Diagnosis1997;41(4):400‐3. ">Saxena 1997</a> so this was also judged to be at low risk of possible bias in random sequence generation. </p> <p>In <a href="./references#CD010196-bbs2-0001" title="EUCTR2005‐004150‐27‐AT . Randomized controlled trial comparing two heparinization protocols for prophylaxis of short‐ and long‐term thrombotic complications of pediatric cardiac catheterization the HEARTCAT‐Study (HEparin Anticoagulation Randomised Trial for Cardiac Catheterization). apps.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2005‐004150‐27‐AT (first posted 12 December 2005). HanslikA , KitzmullerE , HaumerM , KarapetianH , ThomK , Salzer‐MuharU , et al. Incidence of thrombotic and bleeding complications during cardiac catheterization in children (HEARTCAT‐study). Journal of Thrombosis and Haemostasis2009;7(Suppl 2):465. HanslikA , KitzmullerE , Mlekusch , W , Salzer‐MuharU , Michel‐BehnkeI , MaleC . Randomized controlled trial comparing two heparinization protocols for prophylaxis of vascular thrombosis during cardiac catheterization in children ‐ the HEARTCAT study. Cardiology in the Young. Conference: 44th Annual Meeting of the Association for European Paediatric Cardiology, AEPC with Joint Sessions with the Japanese Society of Pediatric Cardiology and Cardiac Surgery Innsbruck Austria. 2010; Vol. 20:S39. HanslikA , KitzmullerE , ThomK , HaumerM , MlekuschW , Salzer‐MuharU , et al. Incidence of thrombotic and bleeding complications during cardiac catheterization in children: comparison of high‐dose versus low‐dose heparin protocols. Journal of Thrombosis and Haemostasis2011;9(12):2353‐60. Hanslik , A , Kitzmüller , E , Thom , K , Haumer , M , Salzer‐Muhar , U , Michel‐Behnke , I , Male , C . Comparison of high‐dose versus low‐dose heparinization protocols for prophylaxis of thrombotic complications during cardiac catheterization in children (HEARTCAT study). Hamostaseologie2010;30(1):A14. KitzmullerE , HanslikA , KarapetianH , Salzer‐MuharU , Michel‐BehnkeI , MaleC . Monitoring unfractionated heparin during cardiac catheterization in children – results from the HEARTCAT study. Cardiology in the Young. Conference: 44th Annual Meeting of the Association for European Paediatric Cardiology, AEPC with Joint Sessions with the Japanese Society of Pediatric Cardiology and Cardiac Surgery Innsbruck Austria. 2010; Vol. 20:s95. ">Hanslik 2011</a>, randomization codes were allocated using sequentially numbered, opaque sealed envelopes, which were opened by an assistant in the CC laboratory so this was judged to be at low risk. <a href="./references#CD010196-bbs2-0002" title="SaxenaA , GuptaR , KumarRK , KothariSS , WasirHS . Predictors of arterial thrombosis after diagnostic cardiac catheterization in infants and children randomized to two heparin dosages. Catheterization and Cardiovascular Diagnosis1997;41(4):400‐3. ">Saxena 1997</a> did not provide enough information in this regard so was judged to be at unclear risk. Please refer to <a href="./references#CD010196-sec-0108" title="">Characteristics of included studies</a> for details. </p> </section> <section id="CD010196-sec-0074"> <h4 class="title">Blinding</h4> <p>Patients, physicians performing the CC, those performing the clinical outcome assessment or vascular ultrasound, and the study coordinators were blinded to treatment allocation in <a href="./references#CD010196-bbs2-0001" title="EUCTR2005‐004150‐27‐AT . Randomized controlled trial comparing two heparinization protocols for prophylaxis of short‐ and long‐term thrombotic complications of pediatric cardiac catheterization the HEARTCAT‐Study (HEparin Anticoagulation Randomised Trial for Cardiac Catheterization). apps.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2005‐004150‐27‐AT (first posted 12 December 2005). HanslikA , KitzmullerE , HaumerM , KarapetianH , ThomK , Salzer‐MuharU , et al. Incidence of thrombotic and bleeding complications during cardiac catheterization in children (HEARTCAT‐study). Journal of Thrombosis and Haemostasis2009;7(Suppl 2):465. HanslikA , KitzmullerE , Mlekusch , W , Salzer‐MuharU , Michel‐BehnkeI , MaleC . Randomized controlled trial comparing two heparinization protocols for prophylaxis of vascular thrombosis during cardiac catheterization in children ‐ the HEARTCAT study. Cardiology in the Young. Conference: 44th Annual Meeting of the Association for European Paediatric Cardiology, AEPC with Joint Sessions with the Japanese Society of Pediatric Cardiology and Cardiac Surgery Innsbruck Austria. 2010; Vol. 20:S39. HanslikA , KitzmullerE , ThomK , HaumerM , MlekuschW , Salzer‐MuharU , et al. Incidence of thrombotic and bleeding complications during cardiac catheterization in children: comparison of high‐dose versus low‐dose heparin protocols. Journal of Thrombosis and Haemostasis2011;9(12):2353‐60. Hanslik , A , Kitzmüller , E , Thom , K , Haumer , M , Salzer‐Muhar , U , Michel‐Behnke , I , Male , C . Comparison of high‐dose versus low‐dose heparinization protocols for prophylaxis of thrombotic complications during cardiac catheterization in children (HEARTCAT study). Hamostaseologie2010;30(1):A14. KitzmullerE , HanslikA , KarapetianH , Salzer‐MuharU , Michel‐BehnkeI , MaleC . Monitoring unfractionated heparin during cardiac catheterization in children – results from the HEARTCAT study. Cardiology in the Young. Conference: 44th Annual Meeting of the Association for European Paediatric Cardiology, AEPC with Joint Sessions with the Japanese Society of Pediatric Cardiology and Cardiac Surgery Innsbruck Austria. 2010; Vol. 20:s95. ">Hanslik 2011</a> so we assessed this as low risk for both performance and detection bias. Not enough information was available regarding blinding in <a href="./references#CD010196-bbs2-0002" title="SaxenaA , GuptaR , KumarRK , KothariSS , WasirHS . Predictors of arterial thrombosis after diagnostic cardiac catheterization in infants and children randomized to two heparin dosages. Catheterization and Cardiovascular Diagnosis1997;41(4):400‐3. ">Saxena 1997</a> so we assessed this study as being at an unclear risk of performance and detection bias. Please refer to <a href="./references#CD010196-sec-0108" title="">Characteristics of included studies</a> for details. </p> </section> <section id="CD010196-sec-0075"> <h4 class="title">Incomplete outcome data</h4> <p><a href="./references#CD010196-bbs2-0001" title="EUCTR2005‐004150‐27‐AT . Randomized controlled trial comparing two heparinization protocols for prophylaxis of short‐ and long‐term thrombotic complications of pediatric cardiac catheterization the HEARTCAT‐Study (HEparin Anticoagulation Randomised Trial for Cardiac Catheterization). apps.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2005‐004150‐27‐AT (first posted 12 December 2005). HanslikA , KitzmullerE , HaumerM , KarapetianH , ThomK , Salzer‐MuharU , et al. Incidence of thrombotic and bleeding complications during cardiac catheterization in children (HEARTCAT‐study). Journal of Thrombosis and Haemostasis2009;7(Suppl 2):465. HanslikA , KitzmullerE , Mlekusch , W , Salzer‐MuharU , Michel‐BehnkeI , MaleC . Randomized controlled trial comparing two heparinization protocols for prophylaxis of vascular thrombosis during cardiac catheterization in children ‐ the HEARTCAT study. Cardiology in the Young. Conference: 44th Annual Meeting of the Association for European Paediatric Cardiology, AEPC with Joint Sessions with the Japanese Society of Pediatric Cardiology and Cardiac Surgery Innsbruck Austria. 2010; Vol. 20:S39. HanslikA , KitzmullerE , ThomK , HaumerM , MlekuschW , Salzer‐MuharU , et al. Incidence of thrombotic and bleeding complications during cardiac catheterization in children: comparison of high‐dose versus low‐dose heparin protocols. Journal of Thrombosis and Haemostasis2011;9(12):2353‐60. Hanslik , A , Kitzmüller , E , Thom , K , Haumer , M , Salzer‐Muhar , U , Michel‐Behnke , I , Male , C . Comparison of high‐dose versus low‐dose heparinization protocols for prophylaxis of thrombotic complications during cardiac catheterization in children (HEARTCAT study). Hamostaseologie2010;30(1):A14. KitzmullerE , HanslikA , KarapetianH , Salzer‐MuharU , Michel‐BehnkeI , MaleC . Monitoring unfractionated heparin during cardiac catheterization in children – results from the HEARTCAT study. Cardiology in the Young. Conference: 44th Annual Meeting of the Association for European Paediatric Cardiology, AEPC with Joint Sessions with the Japanese Society of Pediatric Cardiology and Cardiac Surgery Innsbruck Austria. 2010; Vol. 20:s95. ">Hanslik 2011</a> had a total attrition of 8% (11 patients). The investigators of the study provided information regarding the lack of outcome assessment in these 11 patients, which was unlikely to be related to the outcome and was balanced overall across groups. We therefore judged this study to be at low risk of attrition bias. <a href="./references#CD010196-bbs2-0002" title="SaxenaA , GuptaR , KumarRK , KothariSS , WasirHS . Predictors of arterial thrombosis after diagnostic cardiac catheterization in infants and children randomized to two heparin dosages. Catheterization and Cardiovascular Diagnosis1997;41(4):400‐3. ">Saxena 1997</a> reported outcomes for the same number of patients that were randomized and so was also at low risk of attrition bias. Please refer to <a href="./references#CD010196-sec-0108" title="">Characteristics of included studies</a> for details. </p> </section> <section id="CD010196-sec-0076"> <h4 class="title">Selective reporting</h4> <p>Whereas all pre‐specified outcomes were reported in <a href="./references#CD010196-bbs2-0001" title="EUCTR2005‐004150‐27‐AT . Randomized controlled trial comparing two heparinization protocols for prophylaxis of short‐ and long‐term thrombotic complications of pediatric cardiac catheterization the HEARTCAT‐Study (HEparin Anticoagulation Randomised Trial for Cardiac Catheterization). apps.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2005‐004150‐27‐AT (first posted 12 December 2005). HanslikA , KitzmullerE , HaumerM , KarapetianH , ThomK , Salzer‐MuharU , et al. Incidence of thrombotic and bleeding complications during cardiac catheterization in children (HEARTCAT‐study). Journal of Thrombosis and Haemostasis2009;7(Suppl 2):465. HanslikA , KitzmullerE , Mlekusch , W , Salzer‐MuharU , Michel‐BehnkeI , MaleC . Randomized controlled trial comparing two heparinization protocols for prophylaxis of vascular thrombosis during cardiac catheterization in children ‐ the HEARTCAT study. Cardiology in the Young. Conference: 44th Annual Meeting of the Association for European Paediatric Cardiology, AEPC with Joint Sessions with the Japanese Society of Pediatric Cardiology and Cardiac Surgery Innsbruck Austria. 2010; Vol. 20:S39. HanslikA , KitzmullerE , ThomK , HaumerM , MlekuschW , Salzer‐MuharU , et al. Incidence of thrombotic and bleeding complications during cardiac catheterization in children: comparison of high‐dose versus low‐dose heparin protocols. Journal of Thrombosis and Haemostasis2011;9(12):2353‐60. Hanslik , A , Kitzmüller , E , Thom , K , Haumer , M , Salzer‐Muhar , U , Michel‐Behnke , I , Male , C . Comparison of high‐dose versus low‐dose heparinization protocols for prophylaxis of thrombotic complications during cardiac catheterization in children (HEARTCAT study). Hamostaseologie2010;30(1):A14. KitzmullerE , HanslikA , KarapetianH , Salzer‐MuharU , Michel‐BehnkeI , MaleC . Monitoring unfractionated heparin during cardiac catheterization in children – results from the HEARTCAT study. Cardiology in the Young. Conference: 44th Annual Meeting of the Association for European Paediatric Cardiology, AEPC with Joint Sessions with the Japanese Society of Pediatric Cardiology and Cardiac Surgery Innsbruck Austria. 2010; Vol. 20:s95. ">Hanslik 2011</a>, not enough information was available in <a href="./references#CD010196-bbs2-0002" title="SaxenaA , GuptaR , KumarRK , KothariSS , WasirHS . Predictors of arterial thrombosis after diagnostic cardiac catheterization in infants and children randomized to two heparin dosages. Catheterization and Cardiovascular Diagnosis1997;41(4):400‐3. ">Saxena 1997</a> to be sure that selective reporting bias had not occurred. Studies were judged as low and unclear risk respectively. Please refer to <a href="./references#CD010196-sec-0108" title="">Characteristics of included studies</a>. </p> </section> <section id="CD010196-sec-0077"> <h4 class="title">Other potential sources of bias</h4> <p><a href="./references#CD010196-bbs2-0001" title="EUCTR2005‐004150‐27‐AT . Randomized controlled trial comparing two heparinization protocols for prophylaxis of short‐ and long‐term thrombotic complications of pediatric cardiac catheterization the HEARTCAT‐Study (HEparin Anticoagulation Randomised Trial for Cardiac Catheterization). apps.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2005‐004150‐27‐AT (first posted 12 December 2005). HanslikA , KitzmullerE , HaumerM , KarapetianH , ThomK , Salzer‐MuharU , et al. Incidence of thrombotic and bleeding complications during cardiac catheterization in children (HEARTCAT‐study). Journal of Thrombosis and Haemostasis2009;7(Suppl 2):465. HanslikA , KitzmullerE , Mlekusch , W , Salzer‐MuharU , Michel‐BehnkeI , MaleC . Randomized controlled trial comparing two heparinization protocols for prophylaxis of vascular thrombosis during cardiac catheterization in children ‐ the HEARTCAT study. Cardiology in the Young. Conference: 44th Annual Meeting of the Association for European Paediatric Cardiology, AEPC with Joint Sessions with the Japanese Society of Pediatric Cardiology and Cardiac Surgery Innsbruck Austria. 2010; Vol. 20:S39. HanslikA , KitzmullerE , ThomK , HaumerM , MlekuschW , Salzer‐MuharU , et al. Incidence of thrombotic and bleeding complications during cardiac catheterization in children: comparison of high‐dose versus low‐dose heparin protocols. Journal of Thrombosis and Haemostasis2011;9(12):2353‐60. Hanslik , A , Kitzmüller , E , Thom , K , Haumer , M , Salzer‐Muhar , U , Michel‐Behnke , I , Male , C . Comparison of high‐dose versus low‐dose heparinization protocols for prophylaxis of thrombotic complications during cardiac catheterization in children (HEARTCAT study). Hamostaseologie2010;30(1):A14. KitzmullerE , HanslikA , KarapetianH , Salzer‐MuharU , Michel‐BehnkeI , MaleC . Monitoring unfractionated heparin during cardiac catheterization in children – results from the HEARTCAT study. Cardiology in the Young. Conference: 44th Annual Meeting of the Association for European Paediatric Cardiology, AEPC with Joint Sessions with the Japanese Society of Pediatric Cardiology and Cardiac Surgery Innsbruck Austria. 2010; Vol. 20:s95. ">Hanslik 2011</a> was stopped early due to a lower than expected incidence of the outcome, as shown by an interim analysis. As the interim analysis was conducted without breaking the randomization code we believe that this does not represent a source of possible bias. Although reporting was limited, no other sources of bias were identified in <a href="./references#CD010196-bbs2-0002" title="SaxenaA , GuptaR , KumarRK , KothariSS , WasirHS . Predictors of arterial thrombosis after diagnostic cardiac catheterization in infants and children randomized to two heparin dosages. Catheterization and Cardiovascular Diagnosis1997;41(4):400‐3. ">Saxena 1997</a>. Please refer to <a href="./references#CD010196-sec-0108" title="">Characteristics of included studies</a> for further details. </p> </section> </section> <section id="CD010196-sec-0078"> <h3 class="title" id="CD010196-sec-0078">Effects of interventions</h3> <p>See: <a href="./full#CD010196-tbl-0001"><b>Summary of findings for the main comparison</b> Different unfractionated heparin doses for preventing arterial thrombosis in children undergoing cardiac catheterization</a> </p> <section id="CD010196-sec-0079"> <h4 class="title">Primary outcomes</h4> <section id="CD010196-sec-0080"> <h5 class="title">Arterial thrombotic events</h5> <p>Two studies were included in the final analysis of this outcome (<a href="./references#CD010196-bbs2-0001" title="EUCTR2005‐004150‐27‐AT . Randomized controlled trial comparing two heparinization protocols for prophylaxis of short‐ and long‐term thrombotic complications of pediatric cardiac catheterization the HEARTCAT‐Study (HEparin Anticoagulation Randomised Trial for Cardiac Catheterization). apps.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2005‐004150‐27‐AT (first posted 12 December 2005). HanslikA , KitzmullerE , HaumerM , KarapetianH , ThomK , Salzer‐MuharU , et al. Incidence of thrombotic and bleeding complications during cardiac catheterization in children (HEARTCAT‐study). Journal of Thrombosis and Haemostasis2009;7(Suppl 2):465. HanslikA , KitzmullerE , Mlekusch , W , Salzer‐MuharU , Michel‐BehnkeI , MaleC . Randomized controlled trial comparing two heparinization protocols for prophylaxis of vascular thrombosis during cardiac catheterization in children ‐ the HEARTCAT study. Cardiology in the Young. Conference: 44th Annual Meeting of the Association for European Paediatric Cardiology, AEPC with Joint Sessions with the Japanese Society of Pediatric Cardiology and Cardiac Surgery Innsbruck Austria. 2010; Vol. 20:S39. HanslikA , KitzmullerE , ThomK , HaumerM , MlekuschW , Salzer‐MuharU , et al. Incidence of thrombotic and bleeding complications during cardiac catheterization in children: comparison of high‐dose versus low‐dose heparin protocols. Journal of Thrombosis and Haemostasis2011;9(12):2353‐60. Hanslik , A , Kitzmüller , E , Thom , K , Haumer , M , Salzer‐Muhar , U , Michel‐Behnke , I , Male , C . Comparison of high‐dose versus low‐dose heparinization protocols for prophylaxis of thrombotic complications during cardiac catheterization in children (HEARTCAT study). Hamostaseologie2010;30(1):A14. KitzmullerE , HanslikA , KarapetianH , Salzer‐MuharU , Michel‐BehnkeI , MaleC . Monitoring unfractionated heparin during cardiac catheterization in children – results from the HEARTCAT study. Cardiology in the Young. Conference: 44th Annual Meeting of the Association for European Paediatric Cardiology, AEPC with Joint Sessions with the Japanese Society of Pediatric Cardiology and Cardiac Surgery Innsbruck Austria. 2010; Vol. 20:s95. ">Hanslik 2011</a>; <a href="./references#CD010196-bbs2-0002" title="SaxenaA , GuptaR , KumarRK , KothariSS , WasirHS . Predictors of arterial thrombosis after diagnostic cardiac catheterization in infants and children randomized to two heparin dosages. Catheterization and Cardiovascular Diagnosis1997;41(4):400‐3. ">Saxena 1997</a>). No clear difference in the incidence of arterial thrombosis was found between the two arms, compatible with benefits of either high or low unfractionated heparin: RR low‐dose versus high‐dose 1.06 (95% CI 0.58 to 1.92; moderate‐certainty evidence) (<a href="./full#CD010196-tbl-0001">summary of findings Table for the main comparison</a>); RD low‐dose versus high‐dose 0.005 (95% CI ‐0.04 to 0.05). The NNTH for the outcome arterial thrombosis was 212, with 95% CI from a NNTH of 19, via infinity, to a NNTB of 23 (<a href="./references#CD010196-bbs2-0011" title="AltmanD . Confidence intervals for the number needed to treat. BMJ1998;317(7168):1309‐12. ">Altman 1998</a>); I<sup>2</sup> = 0% (<a href="./references#CD010196-fig-0004" title="">Analysis 1.1</a>). </p> </section> <section id="CD010196-sec-0081"> <h5 class="title">Major bleeding events</h5> <p><a href="./references#CD010196-bbs2-0002" title="SaxenaA , GuptaR , KumarRK , KothariSS , WasirHS . Predictors of arterial thrombosis after diagnostic cardiac catheterization in infants and children randomized to two heparin dosages. Catheterization and Cardiovascular Diagnosis1997;41(4):400‐3. ">Saxena 1997</a> reported bleeding events only in a subset of patients receiving additional anticoagulant or thrombolytic therapy and not in all patients; their bleeding event data were therefore not included in this review. </p> <p><a href="./references#CD010196-bbs2-0001" title="EUCTR2005‐004150‐27‐AT . Randomized controlled trial comparing two heparinization protocols for prophylaxis of short‐ and long‐term thrombotic complications of pediatric cardiac catheterization the HEARTCAT‐Study (HEparin Anticoagulation Randomised Trial for Cardiac Catheterization). apps.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2005‐004150‐27‐AT (first posted 12 December 2005). HanslikA , KitzmullerE , HaumerM , KarapetianH , ThomK , Salzer‐MuharU , et al. Incidence of thrombotic and bleeding complications during cardiac catheterization in children (HEARTCAT‐study). Journal of Thrombosis and Haemostasis2009;7(Suppl 2):465. HanslikA , KitzmullerE , Mlekusch , W , Salzer‐MuharU , Michel‐BehnkeI , MaleC . Randomized controlled trial comparing two heparinization protocols for prophylaxis of vascular thrombosis during cardiac catheterization in children ‐ the HEARTCAT study. Cardiology in the Young. Conference: 44th Annual Meeting of the Association for European Paediatric Cardiology, AEPC with Joint Sessions with the Japanese Society of Pediatric Cardiology and Cardiac Surgery Innsbruck Austria. 2010; Vol. 20:S39. HanslikA , KitzmullerE , ThomK , HaumerM , MlekuschW , Salzer‐MuharU , et al. Incidence of thrombotic and bleeding complications during cardiac catheterization in children: comparison of high‐dose versus low‐dose heparin protocols. Journal of Thrombosis and Haemostasis2011;9(12):2353‐60. Hanslik , A , Kitzmüller , E , Thom , K , Haumer , M , Salzer‐Muhar , U , Michel‐Behnke , I , Male , C . Comparison of high‐dose versus low‐dose heparinization protocols for prophylaxis of thrombotic complications during cardiac catheterization in children (HEARTCAT study). Hamostaseologie2010;30(1):A14. KitzmullerE , HanslikA , KarapetianH , Salzer‐MuharU , Michel‐BehnkeI , MaleC . Monitoring unfractionated heparin during cardiac catheterization in children – results from the HEARTCAT study. Cardiology in the Young. Conference: 44th Annual Meeting of the Association for European Paediatric Cardiology, AEPC with Joint Sessions with the Japanese Society of Pediatric Cardiology and Cardiac Surgery Innsbruck Austria. 2010; Vol. 20:s95. ">Hanslik 2011</a> reported no clear difference in the incidence of major bleeding events between study arms: RR low‐dose versus high‐dose 2.96 (95% CI 0.12 to 71.34; moderate‐certainty evidence) (<a href="./full#CD010196-tbl-0001">summary of findings Table for the main comparison</a>); RD 0.01 (95% CI ‐0.02 to 0.05); NNTH 69, with 95% CI from a NNTH of 23, via infinity, to a NNTB of 73 (<a href="./references#CD010196-bbs2-0011" title="AltmanD . Confidence intervals for the number needed to treat. BMJ1998;317(7168):1309‐12. ">Altman 1998</a>). </p> </section> <section id="CD010196-sec-0082"> <h5 class="title">Minor bleeding events</h5> <p><a href="./references#CD010196-bbs2-0001" title="EUCTR2005‐004150‐27‐AT . Randomized controlled trial comparing two heparinization protocols for prophylaxis of short‐ and long‐term thrombotic complications of pediatric cardiac catheterization the HEARTCAT‐Study (HEparin Anticoagulation Randomised Trial for Cardiac Catheterization). apps.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2005‐004150‐27‐AT (first posted 12 December 2005). HanslikA , KitzmullerE , HaumerM , KarapetianH , ThomK , Salzer‐MuharU , et al. Incidence of thrombotic and bleeding complications during cardiac catheterization in children (HEARTCAT‐study). Journal of Thrombosis and Haemostasis2009;7(Suppl 2):465. HanslikA , KitzmullerE , Mlekusch , W , Salzer‐MuharU , Michel‐BehnkeI , MaleC . Randomized controlled trial comparing two heparinization protocols for prophylaxis of vascular thrombosis during cardiac catheterization in children ‐ the HEARTCAT study. Cardiology in the Young. Conference: 44th Annual Meeting of the Association for European Paediatric Cardiology, AEPC with Joint Sessions with the Japanese Society of Pediatric Cardiology and Cardiac Surgery Innsbruck Austria. 2010; Vol. 20:S39. HanslikA , KitzmullerE , ThomK , HaumerM , MlekuschW , Salzer‐MuharU , et al. Incidence of thrombotic and bleeding complications during cardiac catheterization in children: comparison of high‐dose versus low‐dose heparin protocols. Journal of Thrombosis and Haemostasis2011;9(12):2353‐60. Hanslik , A , Kitzmüller , E , Thom , K , Haumer , M , Salzer‐Muhar , U , Michel‐Behnke , I , Male , C . Comparison of high‐dose versus low‐dose heparinization protocols for prophylaxis of thrombotic complications during cardiac catheterization in children (HEARTCAT study). Hamostaseologie2010;30(1):A14. KitzmullerE , HanslikA , KarapetianH , Salzer‐MuharU , Michel‐BehnkeI , MaleC . Monitoring unfractionated heparin during cardiac catheterization in children – results from the HEARTCAT study. Cardiology in the Young. Conference: 44th Annual Meeting of the Association for European Paediatric Cardiology, AEPC with Joint Sessions with the Japanese Society of Pediatric Cardiology and Cardiac Surgery Innsbruck Austria. 2010; Vol. 20:s95. ">Hanslik 2011</a> reported no clear difference in the incidence of minor bleeding events between study arms; RR low‐dose versus high‐dose 1.38 (95% CI 0.46 to 4.13; moderate‐certainty evidence) (<a href="./full#CD010196-tbl-0001">summary of findings Table for the main comparison</a>); RD 0.02 (95% CI ‐0.06 to 0.12); NNTH 36, 95% CI from a NNTH of 8, via infinity, to a NNTB of 15 (<a href="./references#CD010196-bbs2-0011" title="AltmanD . Confidence intervals for the number needed to treat. BMJ1998;317(7168):1309‐12. ">Altman 1998</a>). </p> </section> </section> <section id="CD010196-sec-0083"> <h4 class="title">Secondary outcomes</h4> <section id="CD010196-sec-0084"> <h5 class="title">Other thrombotic events</h5> <p>The study authors of <a href="./references#CD010196-bbs2-0001" title="EUCTR2005‐004150‐27‐AT . Randomized controlled trial comparing two heparinization protocols for prophylaxis of short‐ and long‐term thrombotic complications of pediatric cardiac catheterization the HEARTCAT‐Study (HEparin Anticoagulation Randomised Trial for Cardiac Catheterization). apps.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2005‐004150‐27‐AT (first posted 12 December 2005). HanslikA , KitzmullerE , HaumerM , KarapetianH , ThomK , Salzer‐MuharU , et al. Incidence of thrombotic and bleeding complications during cardiac catheterization in children (HEARTCAT‐study). Journal of Thrombosis and Haemostasis2009;7(Suppl 2):465. HanslikA , KitzmullerE , Mlekusch , W , Salzer‐MuharU , Michel‐BehnkeI , MaleC . Randomized controlled trial comparing two heparinization protocols for prophylaxis of vascular thrombosis during cardiac catheterization in children ‐ the HEARTCAT study. Cardiology in the Young. Conference: 44th Annual Meeting of the Association for European Paediatric Cardiology, AEPC with Joint Sessions with the Japanese Society of Pediatric Cardiology and Cardiac Surgery Innsbruck Austria. 2010; Vol. 20:S39. HanslikA , KitzmullerE , ThomK , HaumerM , MlekuschW , Salzer‐MuharU , et al. Incidence of thrombotic and bleeding complications during cardiac catheterization in children: comparison of high‐dose versus low‐dose heparin protocols. Journal of Thrombosis and Haemostasis2011;9(12):2353‐60. Hanslik , A , Kitzmüller , E , Thom , K , Haumer , M , Salzer‐Muhar , U , Michel‐Behnke , I , Male , C . Comparison of high‐dose versus low‐dose heparinization protocols for prophylaxis of thrombotic complications during cardiac catheterization in children (HEARTCAT study). Hamostaseologie2010;30(1):A14. KitzmullerE , HanslikA , KarapetianH , Salzer‐MuharU , Michel‐BehnkeI , MaleC . Monitoring unfractionated heparin during cardiac catheterization in children – results from the HEARTCAT study. Cardiology in the Young. Conference: 44th Annual Meeting of the Association for European Paediatric Cardiology, AEPC with Joint Sessions with the Japanese Society of Pediatric Cardiology and Cardiac Surgery Innsbruck Austria. 2010; Vol. 20:s95. ">Hanslik 2011</a> reported a non‐significant difference in the incidence of deep vein thrombosis when comparing dose of heparin: RR low‐dose versus high‐dose 0.34 (95% CI 0.01 to 8.28; moderate‐certainty evidence) (<a href="./full#CD010196-tbl-0001">summary of findings Table for the main comparison</a>); RD ‐0.016 (95% CI ‐0.06 to 0.03); NNTB 64, with 95% CI from a NNTH of 68, via infinity, to a NNTB of 22 (<a href="./references#CD010196-bbs2-0011" title="AltmanD . Confidence intervals for the number needed to treat. BMJ1998;317(7168):1309‐12. ">Altman 1998</a>). </p> <p><a href="./references#CD010196-bbs2-0002" title="SaxenaA , GuptaR , KumarRK , KothariSS , WasirHS . Predictors of arterial thrombosis after diagnostic cardiac catheterization in infants and children randomized to two heparin dosages. Catheterization and Cardiovascular Diagnosis1997;41(4):400‐3. ">Saxena 1997</a> did not determine the incidence of venous thrombotic events. </p> </section> <section id="CD010196-sec-0085"> <h5 class="title">Additional side effects of heparin</h5> <p>Neither <a href="./references#CD010196-bbs2-0001" title="EUCTR2005‐004150‐27‐AT . Randomized controlled trial comparing two heparinization protocols for prophylaxis of short‐ and long‐term thrombotic complications of pediatric cardiac catheterization the HEARTCAT‐Study (HEparin Anticoagulation Randomised Trial for Cardiac Catheterization). apps.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2005‐004150‐27‐AT (first posted 12 December 2005). HanslikA , KitzmullerE , HaumerM , KarapetianH , ThomK , Salzer‐MuharU , et al. Incidence of thrombotic and bleeding complications during cardiac catheterization in children (HEARTCAT‐study). Journal of Thrombosis and Haemostasis2009;7(Suppl 2):465. HanslikA , KitzmullerE , Mlekusch , W , Salzer‐MuharU , Michel‐BehnkeI , MaleC . Randomized controlled trial comparing two heparinization protocols for prophylaxis of vascular thrombosis during cardiac catheterization in children ‐ the HEARTCAT study. Cardiology in the Young. Conference: 44th Annual Meeting of the Association for European Paediatric Cardiology, AEPC with Joint Sessions with the Japanese Society of Pediatric Cardiology and Cardiac Surgery Innsbruck Austria. 2010; Vol. 20:S39. HanslikA , KitzmullerE , ThomK , HaumerM , MlekuschW , Salzer‐MuharU , et al. Incidence of thrombotic and bleeding complications during cardiac catheterization in children: comparison of high‐dose versus low‐dose heparin protocols. Journal of Thrombosis and Haemostasis2011;9(12):2353‐60. Hanslik , A , Kitzmüller , E , Thom , K , Haumer , M , Salzer‐Muhar , U , Michel‐Behnke , I , Male , C . Comparison of high‐dose versus low‐dose heparinization protocols for prophylaxis of thrombotic complications during cardiac catheterization in children (HEARTCAT study). Hamostaseologie2010;30(1):A14. KitzmullerE , HanslikA , KarapetianH , Salzer‐MuharU , Michel‐BehnkeI , MaleC . Monitoring unfractionated heparin during cardiac catheterization in children – results from the HEARTCAT study. Cardiology in the Young. Conference: 44th Annual Meeting of the Association for European Paediatric Cardiology, AEPC with Joint Sessions with the Japanese Society of Pediatric Cardiology and Cardiac Surgery Innsbruck Austria. 2010; Vol. 20:s95. ">Hanslik 2011</a> or <a href="./references#CD010196-bbs2-0002" title="SaxenaA , GuptaR , KumarRK , KothariSS , WasirHS . Predictors of arterial thrombosis after diagnostic cardiac catheterization in infants and children randomized to two heparin dosages. Catheterization and Cardiovascular Diagnosis1997;41(4):400‐3. ">Saxena 1997</a> reported on additional or secondary side effects of heparin use. </p> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD010196-sec-0086" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD010196-sec-0086"></div> <section id="CD010196-sec-0087"> <h3 class="title" id="CD010196-sec-0087">Summary of main results</h3> <p>See <a href="./full#CD010196-tbl-0001">summary of findings Table for the main comparison</a>. </p> <p>Hanslik conducted a randomized trial comparing high versus low doses of heparin in 137 pediatric patients (<a href="./references#CD010196-bbs2-0001" title="EUCTR2005‐004150‐27‐AT . Randomized controlled trial comparing two heparinization protocols for prophylaxis of short‐ and long‐term thrombotic complications of pediatric cardiac catheterization the HEARTCAT‐Study (HEparin Anticoagulation Randomised Trial for Cardiac Catheterization). apps.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2005‐004150‐27‐AT (first posted 12 December 2005). HanslikA , KitzmullerE , HaumerM , KarapetianH , ThomK , Salzer‐MuharU , et al. Incidence of thrombotic and bleeding complications during cardiac catheterization in children (HEARTCAT‐study). Journal of Thrombosis and Haemostasis2009;7(Suppl 2):465. HanslikA , KitzmullerE , Mlekusch , W , Salzer‐MuharU , Michel‐BehnkeI , MaleC . Randomized controlled trial comparing two heparinization protocols for prophylaxis of vascular thrombosis during cardiac catheterization in children ‐ the HEARTCAT study. Cardiology in the Young. Conference: 44th Annual Meeting of the Association for European Paediatric Cardiology, AEPC with Joint Sessions with the Japanese Society of Pediatric Cardiology and Cardiac Surgery Innsbruck Austria. 2010; Vol. 20:S39. HanslikA , KitzmullerE , ThomK , HaumerM , MlekuschW , Salzer‐MuharU , et al. Incidence of thrombotic and bleeding complications during cardiac catheterization in children: comparison of high‐dose versus low‐dose heparin protocols. Journal of Thrombosis and Haemostasis2011;9(12):2353‐60. Hanslik , A , Kitzmüller , E , Thom , K , Haumer , M , Salzer‐Muhar , U , Michel‐Behnke , I , Male , C . Comparison of high‐dose versus low‐dose heparinization protocols for prophylaxis of thrombotic complications during cardiac catheterization in children (HEARTCAT study). Hamostaseologie2010;30(1):A14. KitzmullerE , HanslikA , KarapetianH , Salzer‐MuharU , Michel‐BehnkeI , MaleC . Monitoring unfractionated heparin during cardiac catheterization in children – results from the HEARTCAT study. Cardiology in the Young. Conference: 44th Annual Meeting of the Association for European Paediatric Cardiology, AEPC with Joint Sessions with the Japanese Society of Pediatric Cardiology and Cardiac Surgery Innsbruck Austria. 2010; Vol. 20:s95. ">Hanslik 2011</a>). Blinded interim analysis showed lower than expected occurrence of events, which led to recalculation of the study sample size. The required number of patients was 10 times larger than the initial estimation. The trial was therefore stopped and the data were analyzed. <a href="./references#CD010196-bbs2-0002" title="SaxenaA , GuptaR , KumarRK , KothariSS , WasirHS . Predictors of arterial thrombosis after diagnostic cardiac catheterization in infants and children randomized to two heparin dosages. Catheterization and Cardiovascular Diagnosis1997;41(4):400‐3. ">Saxena 1997</a> provided data on the incidence of arterial thrombosis in 366 children receiving a low versus a high dose of heparin. Neither trial found differences in the incidence of arterial thrombotic events when comparing the two heparin regimens. The confidence interval (CI) for the risk of arterial thrombotic events was compatible with benefits of either high‐ or low‐dose unfractionated heparin regimens (RR low‐dose versus high‐dose 1.06, 95% CI 0.58 to 1.92). </p> <p><a href="./references#CD010196-bbs2-0001" title="EUCTR2005‐004150‐27‐AT . Randomized controlled trial comparing two heparinization protocols for prophylaxis of short‐ and long‐term thrombotic complications of pediatric cardiac catheterization the HEARTCAT‐Study (HEparin Anticoagulation Randomised Trial for Cardiac Catheterization). apps.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2005‐004150‐27‐AT (first posted 12 December 2005). HanslikA , KitzmullerE , HaumerM , KarapetianH , ThomK , Salzer‐MuharU , et al. Incidence of thrombotic and bleeding complications during cardiac catheterization in children (HEARTCAT‐study). Journal of Thrombosis and Haemostasis2009;7(Suppl 2):465. HanslikA , KitzmullerE , Mlekusch , W , Salzer‐MuharU , Michel‐BehnkeI , MaleC . Randomized controlled trial comparing two heparinization protocols for prophylaxis of vascular thrombosis during cardiac catheterization in children ‐ the HEARTCAT study. Cardiology in the Young. Conference: 44th Annual Meeting of the Association for European Paediatric Cardiology, AEPC with Joint Sessions with the Japanese Society of Pediatric Cardiology and Cardiac Surgery Innsbruck Austria. 2010; Vol. 20:S39. HanslikA , KitzmullerE , ThomK , HaumerM , MlekuschW , Salzer‐MuharU , et al. Incidence of thrombotic and bleeding complications during cardiac catheterization in children: comparison of high‐dose versus low‐dose heparin protocols. Journal of Thrombosis and Haemostasis2011;9(12):2353‐60. Hanslik , A , Kitzmüller , E , Thom , K , Haumer , M , Salzer‐Muhar , U , Michel‐Behnke , I , Male , C . Comparison of high‐dose versus low‐dose heparinization protocols for prophylaxis of thrombotic complications during cardiac catheterization in children (HEARTCAT study). Hamostaseologie2010;30(1):A14. KitzmullerE , HanslikA , KarapetianH , Salzer‐MuharU , Michel‐BehnkeI , MaleC . Monitoring unfractionated heparin during cardiac catheterization in children – results from the HEARTCAT study. Cardiology in the Young. Conference: 44th Annual Meeting of the Association for European Paediatric Cardiology, AEPC with Joint Sessions with the Japanese Society of Pediatric Cardiology and Cardiac Surgery Innsbruck Austria. 2010; Vol. 20:s95. ">Hanslik 2011</a> did not find a clear difference in the incidence of major or minor bleeding events and in venous thrombosis between high and low heparin doses. <a href="./references#CD010196-bbs2-0002" title="SaxenaA , GuptaR , KumarRK , KothariSS , WasirHS . Predictors of arterial thrombosis after diagnostic cardiac catheterization in infants and children randomized to two heparin dosages. Catheterization and Cardiovascular Diagnosis1997;41(4):400‐3. ">Saxena 1997</a> did not provide sufficient information for these outcomes. </p> <p>Neither <a href="./references#CD010196-bbs2-0001" title="EUCTR2005‐004150‐27‐AT . Randomized controlled trial comparing two heparinization protocols for prophylaxis of short‐ and long‐term thrombotic complications of pediatric cardiac catheterization the HEARTCAT‐Study (HEparin Anticoagulation Randomised Trial for Cardiac Catheterization). apps.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2005‐004150‐27‐AT (first posted 12 December 2005). HanslikA , KitzmullerE , HaumerM , KarapetianH , ThomK , Salzer‐MuharU , et al. Incidence of thrombotic and bleeding complications during cardiac catheterization in children (HEARTCAT‐study). Journal of Thrombosis and Haemostasis2009;7(Suppl 2):465. HanslikA , KitzmullerE , Mlekusch , W , Salzer‐MuharU , Michel‐BehnkeI , MaleC . Randomized controlled trial comparing two heparinization protocols for prophylaxis of vascular thrombosis during cardiac catheterization in children ‐ the HEARTCAT study. Cardiology in the Young. Conference: 44th Annual Meeting of the Association for European Paediatric Cardiology, AEPC with Joint Sessions with the Japanese Society of Pediatric Cardiology and Cardiac Surgery Innsbruck Austria. 2010; Vol. 20:S39. HanslikA , KitzmullerE , ThomK , HaumerM , MlekuschW , Salzer‐MuharU , et al. Incidence of thrombotic and bleeding complications during cardiac catheterization in children: comparison of high‐dose versus low‐dose heparin protocols. Journal of Thrombosis and Haemostasis2011;9(12):2353‐60. Hanslik , A , Kitzmüller , E , Thom , K , Haumer , M , Salzer‐Muhar , U , Michel‐Behnke , I , Male , C . Comparison of high‐dose versus low‐dose heparinization protocols for prophylaxis of thrombotic complications during cardiac catheterization in children (HEARTCAT study). Hamostaseologie2010;30(1):A14. KitzmullerE , HanslikA , KarapetianH , Salzer‐MuharU , Michel‐BehnkeI , MaleC . Monitoring unfractionated heparin during cardiac catheterization in children – results from the HEARTCAT study. Cardiology in the Young. Conference: 44th Annual Meeting of the Association for European Paediatric Cardiology, AEPC with Joint Sessions with the Japanese Society of Pediatric Cardiology and Cardiac Surgery Innsbruck Austria. 2010; Vol. 20:s95. ">Hanslik 2011</a> nor <a href="./references#CD010196-bbs2-0002" title="SaxenaA , GuptaR , KumarRK , KothariSS , WasirHS . Predictors of arterial thrombosis after diagnostic cardiac catheterization in infants and children randomized to two heparin dosages. Catheterization and Cardiovascular Diagnosis1997;41(4):400‐3. ">Saxena 1997</a> reported additional side effects of heparin. </p> </section> <section id="CD010196-sec-0088"> <h3 class="title" id="CD010196-sec-0088">Overall completeness and applicability of evidence</h3> <p>Two trials met our inclusion criteria (<a href="./references#CD010196-bbs2-0001" title="EUCTR2005‐004150‐27‐AT . Randomized controlled trial comparing two heparinization protocols for prophylaxis of short‐ and long‐term thrombotic complications of pediatric cardiac catheterization the HEARTCAT‐Study (HEparin Anticoagulation Randomised Trial for Cardiac Catheterization). apps.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2005‐004150‐27‐AT (first posted 12 December 2005). HanslikA , KitzmullerE , HaumerM , KarapetianH , ThomK , Salzer‐MuharU , et al. Incidence of thrombotic and bleeding complications during cardiac catheterization in children (HEARTCAT‐study). Journal of Thrombosis and Haemostasis2009;7(Suppl 2):465. HanslikA , KitzmullerE , Mlekusch , W , Salzer‐MuharU , Michel‐BehnkeI , MaleC . Randomized controlled trial comparing two heparinization protocols for prophylaxis of vascular thrombosis during cardiac catheterization in children ‐ the HEARTCAT study. Cardiology in the Young. Conference: 44th Annual Meeting of the Association for European Paediatric Cardiology, AEPC with Joint Sessions with the Japanese Society of Pediatric Cardiology and Cardiac Surgery Innsbruck Austria. 2010; Vol. 20:S39. HanslikA , KitzmullerE , ThomK , HaumerM , MlekuschW , Salzer‐MuharU , et al. Incidence of thrombotic and bleeding complications during cardiac catheterization in children: comparison of high‐dose versus low‐dose heparin protocols. Journal of Thrombosis and Haemostasis2011;9(12):2353‐60. Hanslik , A , Kitzmüller , E , Thom , K , Haumer , M , Salzer‐Muhar , U , Michel‐Behnke , I , Male , C . Comparison of high‐dose versus low‐dose heparinization protocols for prophylaxis of thrombotic complications during cardiac catheterization in children (HEARTCAT study). Hamostaseologie2010;30(1):A14. KitzmullerE , HanslikA , KarapetianH , Salzer‐MuharU , Michel‐BehnkeI , MaleC . Monitoring unfractionated heparin during cardiac catheterization in children – results from the HEARTCAT study. Cardiology in the Young. Conference: 44th Annual Meeting of the Association for European Paediatric Cardiology, AEPC with Joint Sessions with the Japanese Society of Pediatric Cardiology and Cardiac Surgery Innsbruck Austria. 2010; Vol. 20:s95. ">Hanslik 2011</a>; <a href="./references#CD010196-bbs2-0002" title="SaxenaA , GuptaR , KumarRK , KothariSS , WasirHS . Predictors of arterial thrombosis after diagnostic cardiac catheterization in infants and children randomized to two heparin dosages. Catheterization and Cardiovascular Diagnosis1997;41(4):400‐3. ">Saxena 1997</a>). As regards generalizability of the findings, all relevant types of patients and interventions were included. However, whereas arterial thrombotic events were reported in both trials, bleeding events were not reported in one of the studies, and other complications associated with the use of heparin were not reported in either study. </p> </section> <section id="CD010196-sec-0089"> <h3 class="title" id="CD010196-sec-0089">Quality of the evidence</h3> <p>Overall, the certainty of evidence was judged to be moderate for all outcomes due to imprecision of results and the potential limitations in the design and implementation of one of the available studies (<a href="./full#CD010196-tbl-0001">summary of findings Table for the main comparison</a>). Indeed, one of the included trials (<a href="./references#CD010196-bbs2-0002" title="SaxenaA , GuptaR , KumarRK , KothariSS , WasirHS . Predictors of arterial thrombosis after diagnostic cardiac catheterization in infants and children randomized to two heparin dosages. Catheterization and Cardiovascular Diagnosis1997;41(4):400‐3. ">Saxena 1997</a>) did not adequately describe the methods utilized for allocation concealment and blinding, thus severely limiting the possibility of assessing its selection, detection, and performance bias. </p> <p>Importantly, the two studies differ in the detection method used to diagnose arterial thrombosis. Whereas <a href="./references#CD010196-bbs2-0002" title="SaxenaA , GuptaR , KumarRK , KothariSS , WasirHS . Predictors of arterial thrombosis after diagnostic cardiac catheterization in infants and children randomized to two heparin dosages. Catheterization and Cardiovascular Diagnosis1997;41(4):400‐3. ">Saxena 1997</a> used clinical assessment, which is currently widely used in clinical practice, <a href="./references#CD010196-bbs2-0001" title="EUCTR2005‐004150‐27‐AT . Randomized controlled trial comparing two heparinization protocols for prophylaxis of short‐ and long‐term thrombotic complications of pediatric cardiac catheterization the HEARTCAT‐Study (HEparin Anticoagulation Randomised Trial for Cardiac Catheterization). apps.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2005‐004150‐27‐AT (first posted 12 December 2005). HanslikA , KitzmullerE , HaumerM , KarapetianH , ThomK , Salzer‐MuharU , et al. Incidence of thrombotic and bleeding complications during cardiac catheterization in children (HEARTCAT‐study). Journal of Thrombosis and Haemostasis2009;7(Suppl 2):465. HanslikA , KitzmullerE , Mlekusch , W , Salzer‐MuharU , Michel‐BehnkeI , MaleC . Randomized controlled trial comparing two heparinization protocols for prophylaxis of vascular thrombosis during cardiac catheterization in children ‐ the HEARTCAT study. Cardiology in the Young. Conference: 44th Annual Meeting of the Association for European Paediatric Cardiology, AEPC with Joint Sessions with the Japanese Society of Pediatric Cardiology and Cardiac Surgery Innsbruck Austria. 2010; Vol. 20:S39. HanslikA , KitzmullerE , ThomK , HaumerM , MlekuschW , Salzer‐MuharU , et al. Incidence of thrombotic and bleeding complications during cardiac catheterization in children: comparison of high‐dose versus low‐dose heparin protocols. Journal of Thrombosis and Haemostasis2011;9(12):2353‐60. Hanslik , A , Kitzmüller , E , Thom , K , Haumer , M , Salzer‐Muhar , U , Michel‐Behnke , I , Male , C . Comparison of high‐dose versus low‐dose heparinization protocols for prophylaxis of thrombotic complications during cardiac catheterization in children (HEARTCAT study). Hamostaseologie2010;30(1):A14. KitzmullerE , HanslikA , KarapetianH , Salzer‐MuharU , Michel‐BehnkeI , MaleC . Monitoring unfractionated heparin during cardiac catheterization in children – results from the HEARTCAT study. Cardiology in the Young. Conference: 44th Annual Meeting of the Association for European Paediatric Cardiology, AEPC with Joint Sessions with the Japanese Society of Pediatric Cardiology and Cardiac Surgery Innsbruck Austria. 2010; Vol. 20:s95. ">Hanslik 2011</a> used Doppler US. Interestingly, <a href="./references#CD010196-bbs2-0001" title="EUCTR2005‐004150‐27‐AT . Randomized controlled trial comparing two heparinization protocols for prophylaxis of short‐ and long‐term thrombotic complications of pediatric cardiac catheterization the HEARTCAT‐Study (HEparin Anticoagulation Randomised Trial for Cardiac Catheterization). apps.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2005‐004150‐27‐AT (first posted 12 December 2005). HanslikA , KitzmullerE , HaumerM , KarapetianH , ThomK , Salzer‐MuharU , et al. Incidence of thrombotic and bleeding complications during cardiac catheterization in children (HEARTCAT‐study). Journal of Thrombosis and Haemostasis2009;7(Suppl 2):465. HanslikA , KitzmullerE , Mlekusch , W , Salzer‐MuharU , Michel‐BehnkeI , MaleC . Randomized controlled trial comparing two heparinization protocols for prophylaxis of vascular thrombosis during cardiac catheterization in children ‐ the HEARTCAT study. Cardiology in the Young. Conference: 44th Annual Meeting of the Association for European Paediatric Cardiology, AEPC with Joint Sessions with the Japanese Society of Pediatric Cardiology and Cardiac Surgery Innsbruck Austria. 2010; Vol. 20:S39. HanslikA , KitzmullerE , ThomK , HaumerM , MlekuschW , Salzer‐MuharU , et al. Incidence of thrombotic and bleeding complications during cardiac catheterization in children: comparison of high‐dose versus low‐dose heparin protocols. Journal of Thrombosis and Haemostasis2011;9(12):2353‐60. Hanslik , A , Kitzmüller , E , Thom , K , Haumer , M , Salzer‐Muhar , U , Michel‐Behnke , I , Male , C . Comparison of high‐dose versus low‐dose heparinization protocols for prophylaxis of thrombotic complications during cardiac catheterization in children (HEARTCAT study). Hamostaseologie2010;30(1):A14. KitzmullerE , HanslikA , KarapetianH , Salzer‐MuharU , Michel‐BehnkeI , MaleC . Monitoring unfractionated heparin during cardiac catheterization in children – results from the HEARTCAT study. Cardiology in the Young. Conference: 44th Annual Meeting of the Association for European Paediatric Cardiology, AEPC with Joint Sessions with the Japanese Society of Pediatric Cardiology and Cardiac Surgery Innsbruck Austria. 2010; Vol. 20:s95. ">Hanslik 2011</a> also recorded absent or weak pulses. In their study, two of the six patients with arterial thrombosis as per Doppler US assessment had absent pulses, and four of the six had weak pulses; conversely, five of 196 patients without arterial thrombosis in their Doppler US had absent pulses, for a sensibility of clinical assessment in their practice of 33% (if considering only absent pulses) and specificity approaching 98%. It should be pointed out that a different study (<a href="./references#CD010196-bbs2-0038" title="KulkarniS , NaiduR . Vascular ultrasound imaging to study immediate post catheterization vascular complications in children. Catheterization and Cardiovascular Interventions2006;68(3):450‐5. ">Kulkarni 2006</a>) that performed pre‐ and post‐procedural Doppler US and clinical assessment in children of similar age (mean age 56 months) undergoing CC found clinical assessment to have 100% sensitivity and 98% specificity in the detection of arterial thrombosis. </p> </section> <section id="CD010196-sec-0090"> <h3 class="title" id="CD010196-sec-0090">Potential biases in the review process</h3> <p>Every effort was made to minimize the likelihood of missing published and unpublished trials. Our search was comprehensive and not limited to a particular language. Authors were contacted to fill in the data missing in the original publications. However, a limitation of this review is that it was not possible to collect all relevant information from the included trials, particularly safety data regarding the interventions and methodological aspects such as blinding or allocation concealment. </p> </section> <section id="CD010196-sec-0091"> <h3 class="title" id="CD010196-sec-0091">Agreements and disagreements with other studies or reviews</h3> <p>Several prospective studies have reported the incidence of arterial thrombosis in children undergoing CC (<a href="./references#CD010196-bbs2-0024" title="GirodDA , HurwitzRA , CaldwellRL . Heparinization for prevention of thrombosis following pediatric percutaneous arterial catheterization. Pediatric Cardiology1982;3(2):175‐80. ">Girod 1982</a>; <a href="./references#CD010196-bbs2-0025" title="GlatzAC , ShahSS , McCarthyAL , GeisserD , DanielsK , XieD . Prevalence of and risk factors for acute occlusive arterial injury following pediatric cardiac catheterization: a large single‐center cohort study. Catheterization and Cardiovascular Interventions2013;82(3):454‐62. ">Glatz 2013</a>; <a href="./references#CD010196-bbs2-0027" title="GradyRM , EisenbergPR , BridgesND . Rational approach to use of heparin during cardiac catheterization in children. Journal of the American College of Cardiology1995;25(3):725‐9. ">Grady 1995</a>; <a href="./references#CD010196-bbs2-0035" title="InoT , BensonLN , FreedomRM , BarkerGA , AipurskyA , RoweRD . Thrombolytic therapy for femoral artery thrombosis after pediatric cardiac catheterization. American Heart Journal1988;115(3):633‐9. ">Ino 1988</a>; <a href="./references#CD010196-bbs2-0038" title="KulkarniS , NaiduR . Vascular ultrasound imaging to study immediate post catheterization vascular complications in children. Catheterization and Cardiovascular Interventions2006;68(3):450‐5. ">Kulkarni 2006</a>; <a href="./references#CD010196-bbs2-0048" title="NetzH , MaduB , RöhnerG . Heparinization during percutaneous cardiac catheterization in children. Pediatric Cardiology1987;8(3):167‐8. ">Netz 1987</a>; <a href="./references#CD010196-bbs2-0053" title="RuudE , NatvigS , HolmstrømH , WesenbergF . Low prevalence of femoral venous thrombosis after cardiac catheterizations in children: a prospective study. Cardiology in the Young2002;12(6):513‐8. ">Ruud 2002</a>; <a href="./references#CD010196-bbs2-0057" title="VielhaberH , KohlhaseB , KochHG , KehlHG , FliednerM , KececiogluD , et al. Flush heparin during cardiac catheterisation prevents long‐term coagulation activation in children without APC‐resistance‐preliminary results. Thrombosis Research1996;81(6):651‐6. ">Vielhaber 1996</a>; <a href="./references#CD010196-bbs2-0058" title="VitielloR , McCrindleBW , NykanenD , FreedomRM , BensonLN . Complications associated with pediatric cardiac catheterization. Journal of the American College of Cardiology1998;32(5):1433‐40. ">Vitiello 1998</a>). A variety of heparin doses have been utilized, ranging from heparin flushes to 150 units/kg boluses. The incidence of arterial thrombosis has been reported to range from 3.3% to 8.6% of a total 5478 patients receiving initial doses of 150 units/kg of heparin after accessing the arterial site, followed by 75 units/kg in patients older than three months who had procedures lasting more than two hours (<a href="./references#CD010196-bbs2-0035" title="InoT , BensonLN , FreedomRM , BarkerGA , AipurskyA , RoweRD . Thrombolytic therapy for femoral artery thrombosis after pediatric cardiac catheterization. American Heart Journal1988;115(3):633‐9. ">Ino 1988</a>; <a href="./references#CD010196-bbs2-0058" title="VitielloR , McCrindleBW , NykanenD , FreedomRM , BensonLN . Complications associated with pediatric cardiac catheterization. Journal of the American College of Cardiology1998;32(5):1433‐40. ">Vitiello 1998</a>). Two prospective studies found 0% to 0.8% frequency of arterial thrombotic events in a total of 1436 patients receiving an initial dose of 100 units/kg of heparin as a bolus, which in some cases was followed by another 50 units/kg (<a href="./references#CD010196-bbs2-0024" title="GirodDA , HurwitzRA , CaldwellRL . Heparinization for prevention of thrombosis following pediatric percutaneous arterial catheterization. Pediatric Cardiology1982;3(2):175‐80. ">Girod 1982</a>; <a href="./references#CD010196-bbs2-0048" title="NetzH , MaduB , RöhnerG . Heparinization during percutaneous cardiac catheterization in children. Pediatric Cardiology1987;8(3):167‐8. ">Netz 1987</a>). <a href="./references#CD010196-bbs2-0053" title="RuudE , NatvigS , HolmstrømH , WesenbergF . Low prevalence of femoral venous thrombosis after cardiac catheterizations in children: a prospective study. Cardiology in the Young2002;12(6):513‐8. ">Ruud 2002</a> found no thrombotic events in 26 CC procedures involving combined arterial and venous vascular access; their protocol consisted of 75 units/kg of heparin delivered intravenously at the beginning of each arterial catheterization; the same dose was repeated every second hour during the procedure. <a href="./references#CD010196-bbs2-0038" title="KulkarniS , NaiduR . Vascular ultrasound imaging to study immediate post catheterization vascular complications in children. Catheterization and Cardiovascular Interventions2006;68(3):450‐5. ">Kulkarni 2006</a> conducted a prospective study on 120 children undergoing CC, receiving 50 units/kg of heparin. They found a 7.8% incidence of arterial thrombosis, as determined by Doppler US. </p> <p>Two randomized trials compared heparin at a dose of 100 units/kg with placebo, administered either immediately after inserting the arterial catheter (<a href="./references#CD010196-bbs2-0005" title="FreedMD , KeaneJ , RosenthalA . The use of heparinization to prevent arterial thrombosis after percutaneous cardiac catheterization in children. Circulation1974;50:565‐9. ">Freed 1974</a>, n = 161) or on completion of the catheterization (<a href="./references#CD010196-bbs2-0008" title="RaoPS , ThaparMK , RogersJHJr , StrongWB , LutcherCL , NesbitRRJr , et al. Effect of intraarterial injection of heparin on the complications of percutaneous arterial catheterization in infants and children. Catheterization and Cardiovascular Diagnosis1981;7(3):235‐46. ">Rao 1981</a>, n = 116), and reported an 8% to 11% incidence of thrombosis in the heparin arm. One randomized trial compared 100 to 150 units/kg of heparin in 60 children weighing less than 10 kg (<a href="./references#CD010196-bbs2-0003" title="BulbulZR , GalalMO , MahmoudE , NardenB , SolymarL , ChaudharyMA , et al. Arterial complications following cardiac catheterization in children less than 10 kg. Asian Cardiovascular and Thoracic Annals2002;10(2):129‐32. BulbulZR , GalalO , Al FadleyF , JufanMA , AlOS . Arterial complications following cardiac catheterization in children &lt; 10 kg. Randomized to two heparin dosages: a prospective double blinded study. Journal of the Saudi Heart Association2001;13(1):52. ">Bulbul 2002</a>). While no cases of pulse loss were found among 30 children receiving 100 units/kg of heparin, three out of 30 patients (10%) receiving 150 units/kg were reported to have decreased pulses post‐procedure. This study was not included since current pediatric antithrombotic guidelines suggest the use of a UFH dose of 100 units/kg as a bolus, compared with a 50 units/kg dose (<a href="./references#CD010196-bbs2-0046" title="MonagleP , ChanAV , GoldenbergNA , IchordRN , JourneucakeJM , Nowak‐GöttleU , et al. American College of Chest Physicians. Antithrombotic therapy in neonates and children: Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence‐Based Clinical Practice Guidelines. Chest2012;141(2 Suppl):e737S‐801S. ">Monagle 2012</a>), which results in the comparison between low (&lt; 100 units/kg) versus high doses (≥ 100 units/kg), as defined by our review, in a more meaningful clinical comparison. </p> <p>In summary, prospective studies and randomized trials that used a wide range of prophylactic doses of heparin reported a 0% to 11% incidence of arterial thrombosis in pediatric patients post‐CC. Studies using initial doses of 50 to 75 units/kg of heparin reported an incidence of thrombotic events that ranged from 0% to 7.8%, suggesting that lower heparin doses might not be accompanied by an excessive number of arterial thrombotic events when compared to higher doses. A more contemporary, single‐centre cohort study among 3254 patients or 5715 catheterizations reported an overall prevalence of 4.3% arterial occlusions (<a href="./references#CD010196-bbs2-0025" title="GlatzAC , ShahSS , McCarthyAL , GeisserD , DanielsK , XieD . Prevalence of and risk factors for acute occlusive arterial injury following pediatric cardiac catheterization: a large single‐center cohort study. Catheterization and Cardiovascular Interventions2013;82(3):454‐62. ">Glatz 2013</a>). These findings are in keeping with the results of the trials included in this review. </p> <p>Lastly, two studies compared the in vitro effect of heparin doses in children undergoing CC (<a href="./references#CD010196-bbs2-0027" title="GradyRM , EisenbergPR , BridgesND . Rational approach to use of heparin during cardiac catheterization in children. Journal of the American College of Cardiology1995;25(3):725‐9. ">Grady 1995</a>; <a href="./references#CD010196-bbs2-0049" title="NewallF , IgnjatovicV , JohnstonL , SummerhayesR , LaneG , CranswickN , et al. Age is a determinant factor for measures of concentration and effect in children requiring unfractionated heparin. Thrombosis and Haemostasis2010;103(5):1085‐90. ">Newall 2010</a>). In a prospective cohort of 36 pediatric patients (aged 1 month to 19.5 years) undergoing CC, <a href="./references#CD010196-bbs2-0027" title="GradyRM , EisenbergPR , BridgesND . Rational approach to use of heparin during cardiac catheterization in children. Journal of the American College of Cardiology1995;25(3):725‐9. ">Grady 1995</a> investigated the heparin effect reflected by fibrinopeptide A (FPA) as a surrogate for anticoagulation efficacy and by ACT, measured in blood samples. Three patients received only heparin flushes, which failed to suppress FPA or to cause enough anticoagulation reflected by a prolonged ACT; 15 patients received a bolus of 50 units/kg of heparin and 18 patients received a bolus of 100 units/kg. Heparin doses directly correlated with suppression of FPA and ACT prolongation, with higher heparin doses having a superior in vitro anticoagulant effect. Most importantly, above a given prolonged ACT (&gt; 200 seconds) suppression of thrombin activation, reflected by FPA suppression, was successfully achieved irrespective of the initial heparin dose. In a more contemporary prospective study, <a href="./references#CD010196-bbs2-0049" title="NewallF , IgnjatovicV , JohnstonL , SummerhayesR , LaneG , CranswickN , et al. Age is a determinant factor for measures of concentration and effect in children requiring unfractionated heparin. Thrombosis and Haemostasis2010;103(5):1085‐90. ">Newall 2010</a> explored the age‐dependent effect of heparin measured by different laboratory assays in 56 children (aged 0 to 16 years) who underwent a cardiac angiogram. The researchers showed that the heparin concentration was age‐dependent, demonstrating that at a similar dose of heparin (units/kg) the heparin concentration attained is higher in older children; and this age‐dependent difference is attenuated over time after the initial heparin bolus. Moreover, the inhibitory effect of heparin on either activated factors II (FIIa) or FXa also varies with age. In summary, the first study confirmed the progressively higher capacity of increasing heparin doses to promote anticoagulation, also suggesting that if a minimal level of inhibition, reflected by the ACT, is achieved then a further increase in the heparin dose is likely to be irrelevant. The second and more complex study goes beyond these findings suggesting that heparin dosing for children undergoing CC could, in fact, be based on the patient's age rather than on one initial standardized dose of heparin. The main challenge regarding the interpretation of both studies pertains to their translational nature, in that while in vitro studies may provide a physiological plausible mechanism to explain potential clinical differences such findings ought to be confirmed by prospective clinical studies. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD010196-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010196.pub3/media/CDSR/CD010196/urn:x-wiley:14651858:media:CD010196:CD010196-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010196.pub3/media/CDSR/CD010196/image_t/tCD010196-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD010196-fig-0001" src="/cdsr/doi/10.1002/14651858.CD010196.pub3/media/CDSR/CD010196/image_n/nCD010196-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010196.pub3/full#CD010196-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010196.pub3/media/CDSR/CD010196/image_n/nCD010196-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010196-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010196.pub3/media/CDSR/CD010196/urn:x-wiley:14651858:media:CD010196:CD010196-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010196.pub3/media/CDSR/CD010196/image_t/tCD010196-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD010196-fig-0002" src="/cdsr/doi/10.1002/14651858.CD010196.pub3/media/CDSR/CD010196/image_n/nCD010196-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010196.pub3/full#CD010196-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010196.pub3/media/CDSR/CD010196/image_n/nCD010196-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010196-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010196.pub3/media/CDSR/CD010196/urn:x-wiley:14651858:media:CD010196:CD010196-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010196.pub3/media/CDSR/CD010196/image_t/tCD010196-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD010196-fig-0003" src="/cdsr/doi/10.1002/14651858.CD010196.pub3/media/CDSR/CD010196/image_n/nCD010196-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010196.pub3/full#CD010196-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010196.pub3/media/CDSR/CD010196/image_n/nCD010196-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010196-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010196.pub3/media/CDSR/CD010196/urn:x-wiley:14651858:media:CD010196:CD010196-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010196.pub3/media/CDSR/CD010196/image_t/tCD010196-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Low UFH dose compared with high UFH dose, Outcome 1 Arterial thrombosis." data-id="CD010196-fig-0004" src="/cdsr/doi/10.1002/14651858.CD010196.pub3/media/CDSR/CD010196/image_n/nCD010196-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Low UFH dose compared with high UFH dose, Outcome 1 Arterial thrombosis.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010196.pub3/references#CD010196-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010196.pub3/media/CDSR/CD010196/image_n/nCD010196-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD010196-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Different unfractionated heparin doses for preventing arterial thrombosis in children undergoing cardiac catheterization</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Low unfractionated heparin (UFH) dose compared with high UFH dose for prevention of arterial thrombosis during cardiac catheterization (CC)</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> children with congenital heart disease undergoing CC </p> <p><b>Settings:</b> hospital </p> <p><b>Intervention:</b> low doses of UFH (&lt; 100 units/kg) </p> <p><b>Comparison:</b> high doses of UFH (≥ 100 units/kg) </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects * (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>No of Participants<br/> (RCTs)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with high dose UFH</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with low dose UFH</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Arterial thrombotic events</b> </p> <p>(6 to 48 hours after CC)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>7.7 per 100 procedures</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>8.2 per 100 procedures</b><br/> (5.3 to 12.3)<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.06</b> (0.58 to 1.92) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>492<br/> (2) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate<sup>b</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Different detection methods used. <a href="./references#CD010196-bbs2-0002" title="SaxenaA , GuptaR , KumarRK , KothariSS , WasirHS . Predictors of arterial thrombosis after diagnostic cardiac catheterization in infants and children randomized to two heparin dosages. Catheterization and Cardiovascular Diagnosis1997;41(4):400‐3. ">Saxena 1997</a> used clinical assessment and <a href="./references#CD010196-bbs2-0001" title="EUCTR2005‐004150‐27‐AT . Randomized controlled trial comparing two heparinization protocols for prophylaxis of short‐ and long‐term thrombotic complications of pediatric cardiac catheterization the HEARTCAT‐Study (HEparin Anticoagulation Randomised Trial for Cardiac Catheterization). apps.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2005‐004150‐27‐AT (first posted 12 December 2005). HanslikA , KitzmullerE , HaumerM , KarapetianH , ThomK , Salzer‐MuharU , et al. Incidence of thrombotic and bleeding complications during cardiac catheterization in children (HEARTCAT‐study). Journal of Thrombosis and Haemostasis2009;7(Suppl 2):465. HanslikA , KitzmullerE , Mlekusch , W , Salzer‐MuharU , Michel‐BehnkeI , MaleC . Randomized controlled trial comparing two heparinization protocols for prophylaxis of vascular thrombosis during cardiac catheterization in children ‐ the HEARTCAT study. Cardiology in the Young. Conference: 44th Annual Meeting of the Association for European Paediatric Cardiology, AEPC with Joint Sessions with the Japanese Society of Pediatric Cardiology and Cardiac Surgery Innsbruck Austria. 2010; Vol. 20:S39. HanslikA , KitzmullerE , ThomK , HaumerM , MlekuschW , Salzer‐MuharU , et al. Incidence of thrombotic and bleeding complications during cardiac catheterization in children: comparison of high‐dose versus low‐dose heparin protocols. Journal of Thrombosis and Haemostasis2011;9(12):2353‐60. Hanslik , A , Kitzmüller , E , Thom , K , Haumer , M , Salzer‐Muhar , U , Michel‐Behnke , I , Male , C . Comparison of high‐dose versus low‐dose heparinization protocols for prophylaxis of thrombotic complications during cardiac catheterization in children (HEARTCAT study). Hamostaseologie2010;30(1):A14. KitzmullerE , HanslikA , KarapetianH , Salzer‐MuharU , Michel‐BehnkeI , MaleC . Monitoring unfractionated heparin during cardiac catheterization in children – results from the HEARTCAT study. Cardiology in the Young. Conference: 44th Annual Meeting of the Association for European Paediatric Cardiology, AEPC with Joint Sessions with the Japanese Society of Pediatric Cardiology and Cardiac Surgery Innsbruck Austria. 2010; Vol. 20:s95. ">Hanslik 2011</a> used ultrasound assessment </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Major bleeding events</b> </p> <p>(timing not specified)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>0 per 100 procedures</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>1.5 per 100 procedures</b> (&lt; 0.01 to 8)<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 2.96</b> (0.12 to 71.34) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>137</p> <p>(1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate<sup>c</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Only <a href="./references#CD010196-bbs2-0001" title="EUCTR2005‐004150‐27‐AT . Randomized controlled trial comparing two heparinization protocols for prophylaxis of short‐ and long‐term thrombotic complications of pediatric cardiac catheterization the HEARTCAT‐Study (HEparin Anticoagulation Randomised Trial for Cardiac Catheterization). apps.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2005‐004150‐27‐AT (first posted 12 December 2005). HanslikA , KitzmullerE , HaumerM , KarapetianH , ThomK , Salzer‐MuharU , et al. Incidence of thrombotic and bleeding complications during cardiac catheterization in children (HEARTCAT‐study). Journal of Thrombosis and Haemostasis2009;7(Suppl 2):465. HanslikA , KitzmullerE , Mlekusch , W , Salzer‐MuharU , Michel‐BehnkeI , MaleC . Randomized controlled trial comparing two heparinization protocols for prophylaxis of vascular thrombosis during cardiac catheterization in children ‐ the HEARTCAT study. Cardiology in the Young. Conference: 44th Annual Meeting of the Association for European Paediatric Cardiology, AEPC with Joint Sessions with the Japanese Society of Pediatric Cardiology and Cardiac Surgery Innsbruck Austria. 2010; Vol. 20:S39. HanslikA , KitzmullerE , ThomK , HaumerM , MlekuschW , Salzer‐MuharU , et al. Incidence of thrombotic and bleeding complications during cardiac catheterization in children: comparison of high‐dose versus low‐dose heparin protocols. Journal of Thrombosis and Haemostasis2011;9(12):2353‐60. Hanslik , A , Kitzmüller , E , Thom , K , Haumer , M , Salzer‐Muhar , U , Michel‐Behnke , I , Male , C . Comparison of high‐dose versus low‐dose heparinization protocols for prophylaxis of thrombotic complications during cardiac catheterization in children (HEARTCAT study). Hamostaseologie2010;30(1):A14. KitzmullerE , HanslikA , KarapetianH , Salzer‐MuharU , Michel‐BehnkeI , MaleC . Monitoring unfractionated heparin during cardiac catheterization in children – results from the HEARTCAT study. Cardiology in the Young. Conference: 44th Annual Meeting of the Association for European Paediatric Cardiology, AEPC with Joint Sessions with the Japanese Society of Pediatric Cardiology and Cardiac Surgery Innsbruck Austria. 2010; Vol. 20:s95. ">Hanslik 2011</a> reported major bleeding </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Minor bleeding events</b> </p> <p>(timing not specified)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>7.4 per 100 procedures</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>10.1 per 100 procedures</b> (4 to 20)<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.38</b> (0.46 to 4.13) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>137</p> <p>(1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate<sup>c</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Only <a href="./references#CD010196-bbs2-0001" title="EUCTR2005‐004150‐27‐AT . Randomized controlled trial comparing two heparinization protocols for prophylaxis of short‐ and long‐term thrombotic complications of pediatric cardiac catheterization the HEARTCAT‐Study (HEparin Anticoagulation Randomised Trial for Cardiac Catheterization). apps.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2005‐004150‐27‐AT (first posted 12 December 2005). HanslikA , KitzmullerE , HaumerM , KarapetianH , ThomK , Salzer‐MuharU , et al. Incidence of thrombotic and bleeding complications during cardiac catheterization in children (HEARTCAT‐study). Journal of Thrombosis and Haemostasis2009;7(Suppl 2):465. HanslikA , KitzmullerE , Mlekusch , W , Salzer‐MuharU , Michel‐BehnkeI , MaleC . Randomized controlled trial comparing two heparinization protocols for prophylaxis of vascular thrombosis during cardiac catheterization in children ‐ the HEARTCAT study. Cardiology in the Young. Conference: 44th Annual Meeting of the Association for European Paediatric Cardiology, AEPC with Joint Sessions with the Japanese Society of Pediatric Cardiology and Cardiac Surgery Innsbruck Austria. 2010; Vol. 20:S39. HanslikA , KitzmullerE , ThomK , HaumerM , MlekuschW , Salzer‐MuharU , et al. Incidence of thrombotic and bleeding complications during cardiac catheterization in children: comparison of high‐dose versus low‐dose heparin protocols. Journal of Thrombosis and Haemostasis2011;9(12):2353‐60. Hanslik , A , Kitzmüller , E , Thom , K , Haumer , M , Salzer‐Muhar , U , Michel‐Behnke , I , Male , C . Comparison of high‐dose versus low‐dose heparinization protocols for prophylaxis of thrombotic complications during cardiac catheterization in children (HEARTCAT study). Hamostaseologie2010;30(1):A14. KitzmullerE , HanslikA , KarapetianH , Salzer‐MuharU , Michel‐BehnkeI , MaleC . Monitoring unfractionated heparin during cardiac catheterization in children – results from the HEARTCAT study. Cardiology in the Young. Conference: 44th Annual Meeting of the Association for European Paediatric Cardiology, AEPC with Joint Sessions with the Japanese Society of Pediatric Cardiology and Cardiac Surgery Innsbruck Austria. 2010; Vol. 20:s95. ">Hanslik 2011</a> reported minor bleeding </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Other thrombotic events: venous thrombosis</b> </p> <p>(up to 48 hours after CC)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>1.5 per 100 procedures</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>0 per 100 procedures</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.34</b> (0.01 to 8.28) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>126</p> <p>(1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate<sup>c</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Only <a href="./references#CD010196-bbs2-0001" title="EUCTR2005‐004150‐27‐AT . Randomized controlled trial comparing two heparinization protocols for prophylaxis of short‐ and long‐term thrombotic complications of pediatric cardiac catheterization the HEARTCAT‐Study (HEparin Anticoagulation Randomised Trial for Cardiac Catheterization). apps.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2005‐004150‐27‐AT (first posted 12 December 2005). HanslikA , KitzmullerE , HaumerM , KarapetianH , ThomK , Salzer‐MuharU , et al. Incidence of thrombotic and bleeding complications during cardiac catheterization in children (HEARTCAT‐study). Journal of Thrombosis and Haemostasis2009;7(Suppl 2):465. HanslikA , KitzmullerE , Mlekusch , W , Salzer‐MuharU , Michel‐BehnkeI , MaleC . Randomized controlled trial comparing two heparinization protocols for prophylaxis of vascular thrombosis during cardiac catheterization in children ‐ the HEARTCAT study. Cardiology in the Young. Conference: 44th Annual Meeting of the Association for European Paediatric Cardiology, AEPC with Joint Sessions with the Japanese Society of Pediatric Cardiology and Cardiac Surgery Innsbruck Austria. 2010; Vol. 20:S39. HanslikA , KitzmullerE , ThomK , HaumerM , MlekuschW , Salzer‐MuharU , et al. Incidence of thrombotic and bleeding complications during cardiac catheterization in children: comparison of high‐dose versus low‐dose heparin protocols. Journal of Thrombosis and Haemostasis2011;9(12):2353‐60. Hanslik , A , Kitzmüller , E , Thom , K , Haumer , M , Salzer‐Muhar , U , Michel‐Behnke , I , Male , C . Comparison of high‐dose versus low‐dose heparinization protocols for prophylaxis of thrombotic complications during cardiac catheterization in children (HEARTCAT study). Hamostaseologie2010;30(1):A14. KitzmullerE , HanslikA , KarapetianH , Salzer‐MuharU , Michel‐BehnkeI , MaleC . Monitoring unfractionated heparin during cardiac catheterization in children – results from the HEARTCAT study. Cardiology in the Young. Conference: 44th Annual Meeting of the Association for European Paediatric Cardiology, AEPC with Joint Sessions with the Japanese Society of Pediatric Cardiology and Cardiac Surgery Innsbruck Austria. 2010; Vol. 20:s95. ">Hanslik 2011</a> reported venous thrombosis </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Additional side effects of heparin</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Neither <a href="./references#CD010196-bbs2-0001" title="EUCTR2005‐004150‐27‐AT . Randomized controlled trial comparing two heparinization protocols for prophylaxis of short‐ and long‐term thrombotic complications of pediatric cardiac catheterization the HEARTCAT‐Study (HEparin Anticoagulation Randomised Trial for Cardiac Catheterization). apps.who.int/trialsearch/Trial2.aspx?TrialID=EUCTR2005‐004150‐27‐AT (first posted 12 December 2005). HanslikA , KitzmullerE , HaumerM , KarapetianH , ThomK , Salzer‐MuharU , et al. Incidence of thrombotic and bleeding complications during cardiac catheterization in children (HEARTCAT‐study). Journal of Thrombosis and Haemostasis2009;7(Suppl 2):465. HanslikA , KitzmullerE , Mlekusch , W , Salzer‐MuharU , Michel‐BehnkeI , MaleC . Randomized controlled trial comparing two heparinization protocols for prophylaxis of vascular thrombosis during cardiac catheterization in children ‐ the HEARTCAT study. Cardiology in the Young. Conference: 44th Annual Meeting of the Association for European Paediatric Cardiology, AEPC with Joint Sessions with the Japanese Society of Pediatric Cardiology and Cardiac Surgery Innsbruck Austria. 2010; Vol. 20:S39. HanslikA , KitzmullerE , ThomK , HaumerM , MlekuschW , Salzer‐MuharU , et al. Incidence of thrombotic and bleeding complications during cardiac catheterization in children: comparison of high‐dose versus low‐dose heparin protocols. Journal of Thrombosis and Haemostasis2011;9(12):2353‐60. Hanslik , A , Kitzmüller , E , Thom , K , Haumer , M , Salzer‐Muhar , U , Michel‐Behnke , I , Male , C . Comparison of high‐dose versus low‐dose heparinization protocols for prophylaxis of thrombotic complications during cardiac catheterization in children (HEARTCAT study). Hamostaseologie2010;30(1):A14. KitzmullerE , HanslikA , KarapetianH , Salzer‐MuharU , Michel‐BehnkeI , MaleC . Monitoring unfractionated heparin during cardiac catheterization in children – results from the HEARTCAT study. Cardiology in the Young. Conference: 44th Annual Meeting of the Association for European Paediatric Cardiology, AEPC with Joint Sessions with the Japanese Society of Pediatric Cardiology and Cardiac Surgery Innsbruck Austria. 2010; Vol. 20:s95. ">Hanslik 2011</a> or <a href="./references#CD010196-bbs2-0002" title="SaxenaA , GuptaR , KumarRK , KothariSS , WasirHS . Predictors of arterial thrombosis after diagnostic cardiac catheterization in infants and children randomized to two heparin dosages. Catheterization and Cardiovascular Diagnosis1997;41(4):400‐3. ">Saxena 1997</a> reported on additional side effects of heparin use </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CC:</b> Cardiac catheterization;<b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; <b>UFH:</b> Unfractionated heparin; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup> 95% CI by modified Wald method (<a href="./references#CD010196-bbs2-0047" title="MotulskyH . Intuitive biostatistics: a nonmathematical guide to statistical thinking. Oxford University Press, 2010. ">Motulsky 2010</a>)<br/> <sup>b</sup> We downgraded the certainty of the evidence due to imprecision and risk of bias concerns (potential limitations in design and implementation of <a href="./references#CD010196-bbs2-0002" title="SaxenaA , GuptaR , KumarRK , KothariSS , WasirHS . Predictors of arterial thrombosis after diagnostic cardiac catheterization in infants and children randomized to two heparin dosages. Catheterization and Cardiovascular Diagnosis1997;41(4):400‐3. ">Saxena 1997</a>)<br/> <sup>c</sup> We downgraded the certainty of the evidence due to imprecision </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Different unfractionated heparin doses for preventing arterial thrombosis in children undergoing cardiac catheterization</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010196.pub3/full#CD010196-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010196-tbl-0002"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Low UFH dose compared with high UFH dose</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Arterial thrombosis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>492</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.06 [0.58, 1.92]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Low UFH dose compared with high UFH dose</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010196.pub3/references#CD010196-tbl-0002">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD010196.pub3&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD010196-note-0005">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD010196-note-0003">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD010196-note-0004">Français</a> </li> <li class="section-language"> <a class="" href="ko#CD010196-note-0009">한국어</a> </li> <li class="section-language"> <a class="" href="ms#CD010196-note-0011">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="pl#CD010196-note-0010">Polski</a> </li> <li class="section-language"> <a class="" href="ru#CD010196-note-0002">Русский</a> </li> <li class="section-language"> <a class="" href="zh_HANT#CD010196-note-0001">繁體中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734739000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734739000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773542000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773471000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010196\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010196\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010196\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010196\x2epub3"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010196\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010196\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010196\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010196\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010196\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010196\x2epub3"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010196\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010196\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010196\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010196\x2epub3"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010196\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010196\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010196\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010196\x2epub3"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=qy4lqFNF&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010196.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD010196.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD010196.pub3/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD010196.pub3/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010196.pub3%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740728836801"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD010196.pub3/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"/> <span class="taglib-text hide-accessible">Sign In</span> </span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740728836804"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD010196.pub3/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918ece39298e9368',t:'MTc0MDcyODgzNy4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 